2023 Annual Meeting | P3 - Poster Session 03

Date Sunday 04/23/23

Time 05:30 PM - 06:30 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Neuro-oncology, Aging, Dementia, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, ��ɫ��, Research, and Methodology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-ophthalmology/Neuro-otology, Practice, Policy, and Ethics

CME Available 0.00 CME credit

Event Timeline
05:30 PM - 06:30 PM EST	Abstract	9-001 - Seizures in Dementia are Associated with Worse Clinical Outcomes, Higher Mortality and Shorter Lifespans Ifrah Zawar, MD
05:30 PM - 06:30 PM EST	Abstract	9-002 - Clinical characteristics associated with the development of preoperative and postoperative seizures in patients with glioblastoma Sofía S. Sánchez Boluarte, MD
05:30 PM - 06:30 PM EST	Abstract	9-003 - Copy Number Variant Associated with Familial Epilepsy with Wide Phenotypic Spectrum: A Case Series Shashwat Pokharel, MBBS
05:30 PM - 06:30 PM EST	Abstract	9-004 - Post-stroke Epilepsy and its Association with Stroke Location - Meta-analysis Sihyeong Park, MD
05:30 PM - 06:30 PM EST	Abstract	9-005 - S for Seizure? A Case of SMART syndrome Cleo Zarina A. Reyes, MD
05:30 PM - 06:30 PM EST	Abstract	9-006 - Tuberous Sclerosis Complex in Adulthood: A Descriptive Cohort Retrospective Review Jacqueline E. Summers Stromberg, MD
05:30 PM - 06:30 PM EST	Abstract	9-007 - Raising Clinical Suspicion for Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS): Recurrent Seizures, Stroke-like Episodes, and Cortical Atrophy in Young Patients Srikar Tallavajhala
05:30 PM - 06:30 PM EST	Abstract	9-008 - Mowat-Wilson Syndrome; 3 Cases with Characteristic EEG Findings Mohammad A. Shahab, MD, MBBS
05:30 PM - 06:30 PM EST	Abstract	9-009 - Novel ictal manifestations in Leucine rich Glioma Inactivated 1 Encephalitis - Transient, Alternating Hemi-body Paresthesias Susmit Tripathi, MD
05:30 PM - 06:30 PM EST	Abstract	9-010 - A novel CACNA1A variant causing Developmental and Epileptic Encephalopathy 42: Report of the first case in Colombia
05:30 PM - 06:30 PM EST	Abstract	9-011 - Characteristics of Patients With Lennox-Gastaut Syndrome and Predictors for a Longer Stay Following Hospitalization Shaheen Sombans, MBBS
05:30 PM - 06:30 PM EST	Abstract	9-012 - Clinical and Electrographic Features in Beta-Lactam Antibiotic Induced Neurotoxicity Gloria I. Ortiz Guerrero, MD
05:30 PM - 06:30 PM EST	Abstract	15-001 - Use of a Standardized Communication Card Facilitated Patient-as-Teacher Training on Communication Skills and Improved Patient Care in the Neurology Clerkship Carmen Priego
05:30 PM - 06:30 PM EST	Abstract	15-002 - A Night at the Neurocinema: Evaluating the ��ɫ��al Impact of a Neurology-Centric Film Series on a Medical Student Cohort Phil Schmitt, MD
05:30 PM - 06:30 PM EST	Abstract	15-003 - The Neurology Rotation: Evaluation of the Medical Student Experience Jenifer Moceri, DO
05:30 PM - 06:30 PM EST	Abstract	15-004 - Midclerkship Feedback Quality Improvement via Introduction of Simple Form Robert Fekete, MD
05:30 PM - 06:30 PM EST	Abstract	15-005 - Development and implementation of a telephone triage curriculum for neurology residents Midori Eckenstein, MD
05:30 PM - 06:30 PM EST	Abstract	15-006 - Impacting the Culture of Neurologic Care: Piloting a Structural Competency Training into Neurology Core Competencies Sonia Kaur Singh, MD
05:30 PM - 06:30 PM EST	Abstract	3-001 - Identifying Multiple Sclerosis Relapses from Clinical Notes Using Combined Rule-based and Deep Learning Methodologies Iris Chin, PhD
05:30 PM - 06:30 PM EST	Abstract	3-002 - Quality of online materials in MS
05:30 PM - 06:30 PM EST	Abstract	3-003 - ILLUMINATE: Design of a Real-World, Non-Interventional Study Evaluating the Usability and Value of Integrated Digital Solutions for Routine Care of Patients with Multiple Sclerosis Vera Zingler
05:30 PM - 06:30 PM EST	Abstract	3-004 - Subtypes of Relapsing-Remitting Multiple Sclerosis Identified by Network Analysis Quentin Howlett-Prieto
05:30 PM - 06:30 PM EST	Abstract	3-005 - Telehealth Utilization in a Comprehensive Multiple Sclerosis Clinic During the COVID-19 Pandemic: Single Center Experience Trieste Francis
05:30 PM - 06:30 PM EST	Abstract	3-006 - In a Digital Version of the 9-Hole Peg Test, Intra-Task Speed, Accounting for Variance in Distance Traveled, May be a Better Measure of MS-Related Upper-Limb Disability Than Completion Time. Phoebe Jiang, PhD
05:30 PM - 06:30 PM EST	Abstract	3-007 - Financial Burden of Multiple Sclerosis Hospitalizations; A National Study during 2009-2019 in the United States. Sepideh Yadollahi, MD
05:30 PM - 06:30 PM EST	Abstract	3-008 - Working your CoRe : Further Development of a Mobile Cognitive Assessment Application Rod Middleton
05:30 PM - 06:30 PM EST	Abstract	3-009 - Wearing-Off Effect Toward the End of Treatment Cycles in Patients With MS Receiving High-Efficacy Disease-Modifying Therapies: Data From Social Media Listening Ivan John Clement
05:30 PM - 06:30 PM EST	Abstract	3-010 - Validation of an iPad version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) Francesco Sacca, MD, FAAN
05:30 PM - 06:30 PM EST	Abstract	3-011 - Diurnal Step Count Patterns in Progressive Multiple Sclerosis Reza Abbasi-Asl, PhD
05:30 PM - 06:30 PM EST	Abstract	3-012 - Using Natural Language Processing to identify patients with Multiple Sclerosis Rod Middleton
05:30 PM - 06:30 PM EST	Abstract	3-013 - Exploring the Utility of ActiGraph in Measuring Gait Impairment and Physical Activity in Patients with MS Using Digital Biomarkers Sana Syed, MD
05:30 PM - 06:30 PM EST	Abstract	3-015 - Data-driven deep phenotyping of multiple sclerosis patients using patient-reported outcome measures Farren Briggs, PhD
05:30 PM - 06:30 PM EST	Abstract	3-016 - ��ɫ��al Research: Multiple Sclerosis (MS) and Neuroimmunology ��ɫ�� in Neurology Residency Training in the United States Ian L. Dimaandal, MD
05:30 PM - 06:30 PM EST	Abstract	3-017 - Disease Modifying Therapy in Newly Diagnosed People with Multiple Sclerosis – A Real-World Administrative Claims Study Michael L. Edgeworth, MD, MSc, FAAN
05:30 PM - 06:30 PM EST	Abstract	3-018 - AI-based characterization of multiple sclerosis clinical symptomatology using lesion parenchymal fraction: empirical support for the topographical model of MS Stephen Krieger, MD, FAAN
05:30 PM - 06:30 PM EST	Abstract	12-001 - An unusual case of a Puerto Rican patient with involuntary pelvic movements, behavioral changes and mutism associated to VSP13A gene Yesenia Enriquez-Gonzalez, MD
05:30 PM - 06:30 PM EST	Abstract	12-002 - Parkinsonism in a Zambian Man with an unusual occupational exposure Dickson Munkombwe, MD
05:30 PM - 06:30 PM EST	Abstract	12-003 - Subarachnoid Fat Globules Following Spinal Surgery: A Case Report Kehan Zhao, MD
05:30 PM - 06:30 PM EST	Abstract	12-004 - Rare Cortical and Intraparenchymal Epidermoid Cyst within the Right Occipital Lobe Lauren M. Webb, MD
05:30 PM - 06:30 PM EST	Abstract	12-005 - Investigating the use of focused ultrasound to induce blood-brain barrier opening and increase drug delivery into a murine model of primary high grade glioma tumors Samantha Schaevitz
05:30 PM - 06:30 PM EST	Abstract	12-006 - Co-Treatment of Mu-Opioid Endomorphins and a Dipeptidyl Peptidase-IV Inhibitor Increases Amyloid-Beta Clearance and Improves Memory in an Alzheimer’s Cell Model Maxx Yung
05:30 PM - 06:30 PM EST	Abstract	12-007 - ParkinSense: Contactless Parkinson's Disease diagnosis, telemonitoring, and severity analysis via Machine Learning and Multimodal Digital Biomarkers Pulkith Paruchuri
05:30 PM - 06:30 PM EST	Abstract	6-001 - Widespread Aneurysms Secondary to Myosin Light-Chain Kinase Gene Mutation Leading to Multifocal Right Hemispheric Stroke Haroutiun Hamzoian, MD
05:30 PM - 06:30 PM EST	Abstract	6-002 - All Trans Retinoic Acid: A Cerebral Friend or Foe? Chandra Sekhar Mannyam, MBBS
05:30 PM - 06:30 PM EST	Abstract	6-005 - Treatment with rhFGF18 Analog Results in Cerebroprotection and Recovery of Motor and Memory Function in a Rat Model of Acute Ischemic Stroke Alexei Goraltchouk, Other
05:30 PM - 06:30 PM EST	Abstract	6-006 - Glucosamine and Tau protein phosphorylation in a brain permanent-ischemia animal model: a paradoxical effect? Valentina Quintana, Jr., MD
05:30 PM - 06:30 PM EST	Abstract	6-007 - High Immature Platelet Fraction is Associated with Early Neurological Deterioration in Acute Ischemic Stroke Bang-Hoon Cho
05:30 PM - 06:30 PM EST	Abstract	6-008 - Altered angiogenic and neuroinflammatory markers in peripartum individuals with and without severe preeclampsia compared to non-pregnant adults Noora C. Haghighi, MS
05:30 PM - 06:30 PM EST	Abstract	6-009 - Association of gamma-glutamyl transferase variability with risk of venous thrombosis: A nationwide cohort study Sumin Kim, MD
05:30 PM - 06:30 PM EST	Abstract	6-012 - Lower Omega-3 Levels Were Found In Post Stroke Post Traumatic Stress Disorder Swetha Renati, MD
05:30 PM - 06:30 PM EST	Abstract	6-013 - Aldosterone Level Predicts Hypertension After ICH in the REDUCE Trial Julia Zabinska
05:30 PM - 06:30 PM EST	Abstract	6-015 - Diabetes-Related Polygenic Risk Is Associated with Poor Glycemic Control and Higher Risk of Acute Cardiovascular Events in Stroke Survivors Carolyn Conlon
05:30 PM - 06:30 PM EST	Abstract	6-016 - Impaired Kidney Function Small Vessel Disease Markers and Its Association with Periventricular White Matter Hyperintensities Ricardo Murguia Fuentes, MD
05:30 PM - 06:30 PM EST	Abstract	6-017 - Biomarkers as prognostic determinants of epilepsy after post-acute central nervous system insults: a systematic review and meta-analysis Shubham Misra, PhD
05:30 PM - 06:30 PM EST	Abstract	6-018 - Thyroid hormone decreasing after mechanical thrombectomy for cerebral infarction Yuya Kobayashi
05:30 PM - 06:30 PM EST	Abstract	6-019 - Nitinol in Medical Devices: Not so Innocuous Rana K. Zabad, MD, FAAN
05:30 PM - 06:30 PM EST	Abstract	6-020 - Persistent Trigeminal Artery causing anterior and posterior circulation ischemic stroke Saketh Annam, MBBS
05:30 PM - 06:30 PM EST	Abstract	6-021 - CT Perfusion Imaging Guides Clinical Decision Making in a Case of Thalamic Stroke Kasim Qureshi, MD
05:30 PM - 06:30 PM EST	Abstract	6-022 - Linear Scleroderma en Coup de Sabre Presenting with Stroke and Seizure Tatiana Greige, MD
05:30 PM - 06:30 PM EST	Abstract	6-023 - Transient Perivascular Inflammation of the Carotid Artery (TIPIC): A rare cause of Horner’s Syndrome Elizabeth Celente, DO
05:30 PM - 06:30 PM EST	Abstract	6-024 - A rare case of Carotid Dissection seen in Vascular Eagle Syndrome Collette Kokikian, MD
05:30 PM - 06:30 PM EST	Abstract	6-025 - Stroke syndrome Z: Bilateral Symmetrical Corona Radiata strokes causing facial diplegia, anarthria, and quadriparesis mimicking an acute neuromuscular syndrome Azka Shaikh, MD
05:30 PM - 06:30 PM EST	Abstract	6-026 - Cardiac Calcified Amorphous Tumor: An Unusual Etiology for Recurrent Cardioembolic Strokes Rishi Sharma, MD
05:30 PM - 06:30 PM EST	Abstract	6-027 - Sudden Bilateral Sensorineural Hearing Loss due to Basilar Artery Occlusion Marina Buciuc, MD
05:30 PM - 06:30 PM EST	Abstract	6-028 - Periprocedural Cerebral Air Embolism; A Rare and Potentially Fatal Complication of Watchman Device Krithika Umesh Peshwe, MD
05:30 PM - 06:30 PM EST	Abstract	6-029 - Uncommon Presentation of an Uncommon Disease: Stroke-like Migraine Attacks after Radiation Therapy in a Patient with Sudden Onset Expressive Aphasia and Cryptogenic Fevers Sukhraj Gill, MD
05:30 PM - 06:30 PM EST	Abstract	6-030 - A Unique Case of Vestibular Symptoms in Parietal Stroke
05:30 PM - 06:30 PM EST	Abstract	6-031 - Unique Patterns of Ischemic Stroke from Combined Cocaine and Heroin Use: A Case Series Zachariah Hasan, MD
05:30 PM - 06:30 PM EST	Abstract	6-032 - Bow Hunter Syndrome Involving Rare PICA Variant Alexis Trujillo, MD
05:30 PM - 06:30 PM EST	Abstract	7-001 - The Mechanism of Disease of Alzheimer’s and Parkinson Disease Piet C. De Groen, MD
05:30 PM - 06:30 PM EST	Abstract	7-002 - Digital Histological Measurements Show a Range of Values Within Traditional Pathological Metrics of AD-related Tau Pathology David G. Coughlin, MD
05:30 PM - 06:30 PM EST	Abstract	7-003 - Development of a MATLAB-based Toolkit to Quantify Neurodegenerative Histopathology Markers Applied to the Evaluation of a CRISPR-based Therapeutic for Alzheimer’s Disease Nihal Satyadev, MD, MPH
05:30 PM - 06:30 PM EST	Abstract	7-004 - Association of Younger Age and APOE e4 Carrier Status with Cerebral Amyloid Angiopathy in Pure and Mixed Alzheimers Disease Neuropathology Jagan Pillai, MD, PhD, FAAN
05:30 PM - 06:30 PM EST	Abstract	7-005 - Seizure Rates Across Pathologically-Confirmed Dementia Subtypes Lauren R. Moo, MD, FAAN
05:30 PM - 06:30 PM EST	Abstract	7-006 - Comparison of Structural MRI Profiles Between Autopsy-Confirmed Chronic Traumatic Encephalopathy and Alzheimer’s Disease Sydney Mosaheb, MS
05:30 PM - 06:30 PM EST	Abstract	7-007 - Histopathological Analysis of Cerebral Microvasculature Pathology with Alzheimer’s Disease Neuropathological Changes: An Autopsy Study Yuan Cao
05:30 PM - 06:30 PM EST	Abstract	7-008 - Histopathologic Brain Age Estimation via Deep Multiple Instance Learning
05:30 PM - 06:30 PM EST	Abstract	7-009 - Prevalence of Autoantibody Positivity and Associated Neuropathologies in the Oldest-old Ghazaleh Ahmadi Jazi, MD
05:30 PM - 06:30 PM EST	Abstract	7-010 - Arteriolosclerosis Differs from Venular Collagenosis in Relation to Cerebrovascular Parenchymal Damages: An Autopsy-based Study Yuan Cao
05:30 PM - 06:30 PM EST	Abstract	1-001 - Major Drivers of Increased Cost of Inpatient Stroke Care in the Wake of the COVID-19 Pandemic Cathy A. Sila, MD, FAAN
05:30 PM - 06:30 PM EST	Abstract	1-002 - NF1 Recommendation-Based Care Delivery: A Survey of Patients and Caregivers Justin T. Jordan, MD, MPH, FAAN
05:30 PM - 06:30 PM EST	Abstract	1-003 - Minimal acceptable functional outcomes according to surrogates and professionals caring for unconscious patients Jerina Carmona, Other
05:30 PM - 06:30 PM EST	Abstract	1-004 - Improving Consistency in Audits with Human Research Participants: Determining the Optimal Percent of Research Records to Review Matthew Gooden
05:30 PM - 06:30 PM EST	Abstract	1-005 - Impact of Medication Optimization and Recommendations by Clinical Pharmacists Embedded in a Memory Disorder Clinic Anna Mattle, PharmD
05:30 PM - 06:30 PM EST	Abstract	1-006 - Inpatient Neurology Huddle Quality Improvement Project Maryam Matloub, MD
05:30 PM - 06:30 PM EST	Abstract	10-001 - Safety and Tolerability of Losmapimod for the Treatment of FSHD Marie-Helene Jouvin
05:30 PM - 06:30 PM EST	Abstract	10-002 - PGN-EDO51: Preclinical Data Supporting the Development of an Enhanced Delivery Oligonucleotide (EDO) for the Treatment of Duchenne Muscular Dystrophy (DMD) Ashling Holland, PhD
05:30 PM - 06:30 PM EST	Abstract	10-004 - PGN-EDO51, an Enhanced Delivery Oligonucleotide (EDO) for the Treatment of Duchenne Muscular Dystrophy (DMD): Results of a Phase 1 Study in Healthy Volunteers Michelle L. Mellion, MD
05:30 PM - 06:30 PM EST	Abstract	10-005 - EIM Phase Angle as a Candidate Biomarker of Muscle Function in DM1 Patients Thurman M. Wheeler, MD
05:30 PM - 06:30 PM EST	Abstract	10-006 - Long-term Safety and Efficacy in Patients with DMD 4 Years Post-Treatment with Delandistrogene Moxeparvovec (SRP-9001) in a Phase 1/2a Study Stefanie Mason, MD
05:30 PM - 06:30 PM EST	Abstract	10-007 - Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of AOC 1020 Administered Intravenously to Adult Patients with Facioscapulohumeral Muscular Dystrophy (FORTITUDE) Trial Design Han Cho, PharmD
05:30 PM - 06:30 PM EST	Abstract	10-008 - Evaluating Pharmacology and Efficacy of Delandistrogene Moxeparvovec in Young and Aged DMDmdx Rats Kaitlin Dickinson, PhD
05:30 PM - 06:30 PM EST	Abstract	10-009 - Outstripping of Motor Unit Compensation with Disease Severity in Adults with Spinal Muscular Atrophy Adam S. Deardorff, MD
05:30 PM - 06:30 PM EST	Abstract	10-010 - Impact of Nusinersen treatment on quality of life in adult patients with Spinal Muscular Atrophy Felix Guerra Castanon, MD
05:30 PM - 06:30 PM EST	Abstract	10-011 - VRK1 mutation associated with adult-onset spinal muscular atrophy and persistently elevated creatine kinase Octavio Carranza-Renteria, MD
05:30 PM - 06:30 PM EST	Abstract	10-012 - Mills’ Disease Variant Rasha Moussallem, MD
05:30 PM - 06:30 PM EST	Abstract	10-013 - A Rare Case of Hereditary Spastic Paraplegia 46 With Novel Compound Heterozygous GBA2 gene variants Sandeep Gill, MD
05:30 PM - 06:30 PM EST	Abstract	10-014 - Paraneoplastic pure motor neuropathy in a 48-year-old male with recently diagnosed DLBCL Avinash S. Kolli, MD
05:30 PM - 06:30 PM EST	Abstract	10-015 - A Review of Economic Studies of Amyotrophic Lateral Sclerosis (ALS) in the United States Anudeeta Gautam
05:30 PM - 06:30 PM EST	Abstract	4-001 - Phase 1/2 Clinical Study of VRDN-001, A Full Antagonist Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R), in Patients with Thyroid Eye Disease (TED) Mark L. Moster, MD, FAAN
05:30 PM - 06:30 PM EST	Abstract	4-002 - Worldwide Survey on the Treatment of Peripheral Vestibular Disorders Michael Strupp, MD, DO, FAAN
05:30 PM - 06:30 PM EST	Abstract	4-004 - Ocular counter-roll during a Ménière's attack: evidence of ictal utricle pathway imbalance using fundus photography Elizabeth A. Fracica, MD, MPH
05:30 PM - 06:30 PM EST	Abstract	4-005 - Ping-pong gaze with “staircase” saccades in coma: An oculographic analysis using EEG Neel Fotedar, MD
05:30 PM - 06:30 PM EST	Abstract	4-006 - Optokinetic Nystagmus: Five Reasons Why Every Neurologist Should Evaluate It David E. Hale, Jr., MD
05:30 PM - 06:30 PM EST	Abstract	4-007 - Phase 1 Safety and Pharmacodynamic Results of VRDN-001, a Full Antagonist Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R) in Development for Thyroid Eye Disease (TED) Angela She, PhD
05:30 PM - 06:30 PM EST	Abstract	4-008 - A Novel Approach to Assess the Impact of Disease in Patients with SCN8A-Related Developmental and Epileptic Encephalopathy Brian Pfister
05:30 PM - 06:30 PM EST	Abstract	4-009 - Functional Investigation of Somatic Variants in Pediatric Epilepsy Using Single-Cell DNA/RNA Assays from Patient Derived Single Cells Drew L. Cheng
05:30 PM - 06:30 PM EST	Abstract	4-010 - Effect of Fenfluramine on Generalized Tonic-Clonic Seizures in Rare Epilepsy Syndromes: A Review of Published Studies Mallory Alonso, PharmD
05:30 PM - 06:30 PM EST	Abstract	4-011 - A Retrospective Textual Analysis of Sexual and Reproductive Health Counseling for Adolescent and Young Adult Women with Epilepsy Elizabeth Harrison, MD
05:30 PM - 06:30 PM EST	Abstract	4-012 - Racial disparities in genetic testing in children with pediatric epilepsy Rachit Patil, MD
05:30 PM - 06:30 PM EST	Abstract	13-001 - Intracranial Aneurysm In a Case of Tubercular Meningoencephalitis, a Rare Presentation Kuntal Biswas, MD
05:30 PM - 06:30 PM EST	Abstract	13-002 - Tuberculous Meningitis: Is the Fixed Dose Anti-TB treatment strategy effective? Case report from Sri Lanka Shanindra De Alwis, MD, MBBS
05:30 PM - 06:30 PM EST	Abstract	13-003 - Cerebral Sparganosis Presenting with Status Epilepticus in a Young Male Patient Not Having Brain Lesions on MRI Dong Jin Shin, MD
05:30 PM - 06:30 PM EST	Abstract	13-004 - Neuropathy as the Initial Manifestation of Leprosy in an Older Patient Kush Sharma, MBBS
05:30 PM - 06:30 PM EST	Abstract	13-006 - Tissue is Still the Issue: A Unique Case of Culture-Positive CNS MAC Infection and Biopsy-Proven Large B-Cell Lymphoma Sojung Park, DO
05:30 PM - 06:30 PM EST	Abstract	13-007 - Neurocysticercosis in Non-Endemic Areas: The Experience in Qatar Areej Nauman, MD
05:30 PM - 06:30 PM EST	Abstract	5-001 - Clinical Utility of Skin Biopsy Compared to DaTscan in Diagnosing Synucleinopathies Nikita Urval, MD
05:30 PM - 06:30 PM EST	Abstract	5-002 - a-Synuclein membrane-binding in the central and enteric nervous system in Parkinson’s disease Virginia Gao, MD
05:30 PM - 06:30 PM EST	Abstract	5-003 - Retinal age gap as a predictive biomarker of future risk of Parkinson's disease
05:30 PM - 06:30 PM EST	Abstract	5-005 - Updated Parkinson's disease motor subtypes classification and correlation to CSF HVA and 5-HIAA levels Jessika Suescun, MD
05:30 PM - 06:30 PM EST	Abstract	5-007 - Peripheral Sphingolipids as Potential Biomarkers of Parkinson disease Including Sex-Related Differences Roberto A. Ortega, MS
05:30 PM - 06:30 PM EST	Abstract	5-008 - The assessment of inflammation markers IL-1beta and IL-6 before and after FMT in patients with Parkinson’s disease. Karol Sadowski
05:30 PM - 06:30 PM EST	Abstract	5-009 - Blepharoclonus as a Potential Novel Clinical Marker in Parkinson’s Disease Nestor Beltre, MD
05:30 PM - 06:30 PM EST	Abstract	5-010 - In-lab Assessment of a Sternum-Worn Accelerometer to Measure Gait Speed in Healthy Individuals Nunzio Camerlingo, PhD
05:30 PM - 06:30 PM EST	Abstract	5-011 - Metabolomic Profiling of Plasma Samples from PPMI Identifies Molecular Signatures of Parkinson’s Disease and Genetic Parkinson’s Disease Susceptibility Sarah Huntwork-Rodriguez, PhD
05:30 PM - 06:30 PM EST	Abstract	5-012 - Genotype-Phenotype correlation in Parkin-Parkinson’s disease Poornima Jayadev Menon, MbBchBAO, MRCPI
05:30 PM - 06:30 PM EST	Abstract	5-013 - Rare TMEM230 Variants are Potentially Associated With Early Onset Parkinson's Disease Konstantin Senkevich, MD
05:30 PM - 06:30 PM EST	Abstract	5-014 - Impact of PINK1 knockout on expression and phosphorylation of mitochondrial proteins and dopamine regulation: insight into early-stage Parkinson’s Disease in the rat model. Joshia John, MD
05:30 PM - 06:30 PM EST	Abstract	5-015 - Caudal Mediates a Glial Alpha-synuclein Induced Increase in Proteolysis-Related Genes Ming Shen, Other
05:30 PM - 06:30 PM EST	Abstract	2-001 - Longitudinal follow-up of headaches in the context of Post-Acute Sequelae of COVID-19 (PASC) in an outpatient neurology cohort Sara W. Hyman
05:30 PM - 06:30 PM EST	Abstract	2-002 - Quality of Life in Patients with Confirmed and Suspected Spontaneous Intracranial Hypotension Victor Liaw, MD
05:30 PM - 06:30 PM EST	Abstract	2-003 - Neurologic Deficits and cerebrospinal fluid (CSF) lymphocytosis (HaNDL): a comprehensive systematic review of 93 patients from 57 studies Fahham Asghar, MD
05:30 PM - 06:30 PM EST	Abstract	2-004 - Exploring the Experience of Neck Pain in Individuals With Episodic Migraine Darshini Shah, Other
05:30 PM - 06:30 PM EST	Abstract	2-005 - Co-relation of Venous Sinus Changes to Intracranial Pressure in IIH Tonse Ashwini Kini, MBBS
05:30 PM - 06:30 PM EST	Abstract	2-006 - Clinical and Imaging Analysis of Headaches in Neurological Post-acute Sequelae of SARS-CoV-2 Infection Tyler Kuhns, MD
05:30 PM - 06:30 PM EST	Abstract	2-007 - Headache in acute ischemic stroke as a good prognostic factor Alejandro R. Marfil-Rivera, MD
05:30 PM - 06:30 PM EST	Abstract	2-008 - Ketamine Induced RCVS Naaima Mufti, MD
05:30 PM - 06:30 PM EST	Abstract	2-009 - Cerebral Venous Sinus Pressure and Head Pain: A Case of Cough Headache Secondary to Superior Sagittal Sinus Stenosis Taylor Haddad, MD
05:30 PM - 06:30 PM EST	Abstract	2-010 - Migraine Presented as Harlequin Syndrome Anand Kumar, MD, DM
05:30 PM - 06:30 PM EST	Abstract	2-011 - Case Study: A Heart Transplant Recipient with New, Severe Headache Christopher C. Anderson, MD
05:30 PM - 06:30 PM EST	Abstract	2-012 - Real Life Approach to Outpatient Treatment of Status Migrainosus: A Survey Study Jennifer V. Robblee, MD
05:30 PM - 06:30 PM EST	Abstract	11-001 - Treatment Recommendations and Estimation of Toxicity in Older Patients with Glioblastoma Lauryn Hemminger
05:30 PM - 06:30 PM EST	Abstract	11-002 - Prophylactic Anti-Seizure Medication Use in Newly Diagnosed Brain Tumor Patients Marcia E. Morita-Sherman, MD
05:30 PM - 06:30 PM EST	Abstract	11-003 - NeuroPathways: A Novel, Population-Specific Information and Support Intervention for Patients with Newly Diagnosed Primary Malignant Brain Tumors Sumita M. Strander
05:30 PM - 06:30 PM EST	Abstract	11-004 - Overall Survival Outcome In Patients With New Treatment Approaches For Glioblastoma Multiforme In Randomized Controlled Trials María F. Castillo Vaca
05:30 PM - 06:30 PM EST	Abstract	11-005 - Value of Thallium-201 SPECT and SPECT/CT Brain Imaging in Differentiating Malignant from Nonmalignant Lesions: A Comparative Case-Series Study with Pathologic and/or Clinical Correlation Nicole Girlyn T. Pang, MD
05:30 PM - 06:30 PM EST	Abstract	11-006 - Strokes in Patients with Primary Brain Tumors After Radiation Therapy: A Retrospective Cohort Study Dylan T. Ryan, MD

Faculty Disclosures
Vishal Shah, MBBS	Dr. Shah has nothing to disclose.
	No disclosure on file
Yuya Kobayashi	Dr. Kobayashi has nothing to disclose.
Sedat Gul, MD	Dr. Gul has nothing to disclose.
Sujata P. Thawani, MD	Dr. Thawani has nothing to disclose.
Jana Wold, MD	Dr. Wold has nothing to disclose.
Jennifer V. Robblee, MD	Dr. Robblee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Dr. Robblee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Robblee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tonix. An immediate family member of Dr. Robblee has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Scottsdale Providence. The institution of Dr. Robblee has received research support from Eli Lilly. The institution of Dr. Robblee has received research support from AbbVie. The institution of Dr. Robblee has received research support from Barrow Neurological Institute. Dr. Robblee has received publishing royalties from a publication relating to health care. Dr. Robblee has received publishing royalties from a publication relating to health care.
Deanna Saylor, MD, MHS	Dr. Saylor has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from ��ɫ��. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and ��ɫ��al Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities.
Yves Dauvilliers, MD, PhD	Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for idorsia. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for JAZZ. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alkermes. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Centessa. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bioprojet. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony Bioscience.
Cathy A. Sila, MD, FAAN	Dr. Sila has nothing to disclose.
Justin T. Jordan, MD, MPH, FAAN	Dr. Jordan has received personal compensation for serving as an employee of City of Beverly. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Genesis HR Solutions. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Children's Hospital. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shepherd Therapeutics. Dr. Jordan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Jordan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Springworks Therapeutics. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AstraZeneca. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Continental Casualty Company. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for HennLesperance. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Rhoades McKee. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wheeler Trigg O'Donnell. Dr. Jordan has or had stock in Navio Theragnostics. An immediate family member of Dr. Jordan has or had stock in OldGate.Dr. Jordan has or had stock in Shepherd Therapeutics.Dr. Jordan has or had stock in Khora TX. The institution of Dr. Jordan has received research support from NIH. The institution of Dr. Jordan has received research support from Department of Defense. The institution of Dr. Jordan has received research support from PCORI. Dr. Jordan has received publishing royalties from a publication relating to health care. Dr. Jordan has received publishing royalties from a publication relating to health care.
Midori Eckenstein, MD	Dr. Eckenstein has nothing to disclose.
Jordana Cohen	Jordana Cohen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Jordana Cohen has received research support from National Institutes of Health. Jordana Cohen has received publishing royalties from a publication relating to health care.
Carol A. Manning, PhD	The institution of Dr. Manning has received research support from Department of Defense.
Brian Westerhuis, MD	Dr. Westerhuis has nothing to disclose.
Yunxia Wang, MD, FAAN	Dr. Wang has nothing to disclose.
Rajarshi Mazumder, MD, MPH	Dr. Mazumder has nothing to disclose.
Nimish A. Mohile, MD, FAAN	The institution of Dr. Mohile has received research support from Novocure.
Mazen M. Dimachkie, MD, FAAN	Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/Immunovant. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ��ɫ�� (AAN). Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon Biosciences. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Candid Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creyon Bio, Inc.. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig Therapeutics. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB Biopharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fortrea. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kriya Therapeutics. The institution of Dr. Dimachkie has received research support from NIH. The institution of Dr. Dimachkie has received research support from The Myositis Association. The institution of Dr. Dimachkie has received research support from Biosensics. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
Steven Galetta, MD, FAAN	Dr. Galetta has nothing to disclose.
Karen Buch, MD	Karen Buch, MD has nothing to disclose.
Nicole Ullrich, MD, PhD, MMSci, FAAN	The institution of Dr. Ullrich has received research support from Children's Tumor Foundation. Dr. Ullrich has received intellectual property interests from a discovery or technology relating to health care. Dr. Ullrich has received publishing royalties from a publication relating to health care.
Rachel Marie E. Salas, MD, MEd, FAAN	Dr. Salas has received personal compensation for serving as an employee of HMPGlobal. Dr. Salas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Learning Network. Dr. Salas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for PRIME. Dr. Salas has received publishing royalties from a publication relating to health care.
Kehan Zhao, MD	Dr. Zhao has nothing to disclose.
Sara Hardy, MD	Dr. Hardy has received research support from the American Cancer Society.
Shubham Misra, PhD	Dr. Misra has nothing to disclose.
Avinash S. Kolli, MD	Dr. Kolli has nothing to disclose.
Bruce A. Cree, MD, PhD, MAS, FAAN	The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
Andrew H. Ahn, MD, PhD	Dr. Ahn has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Arpita Lakhotia, MD, FAAN	Dr. Lakhotia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Lakhotia has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Tonse Ashwini Kini, MBBS	Dr. Kini has nothing to disclose.
Ashutosh P. Jadhav, MD, FAAN	Dr. Jadhav has nothing to disclose.
Anteneh M. Feyissa, MD, MSc, FAAN	Dr. Feyissa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis.
Asim Z. Mian, MD	Dr. Mian has received personal compensation for serving as an employee of Boston Imaging Core Lab. Dr. Mian has stock in Boston Imaging Core Lab. Dr. Mian has received intellectual property interests from a discovery or technology relating to health care.
Jan Claassen, MD, PhD	Dr. Claassen has stock in iCE Neurosystems. The institution of Dr. Claassen has received research support from NINDS. The institution of Dr. Claassen has received research support from McDonnel Foundation. Dr. Claassen has received publishing royalties from a publication relating to health care. Dr. Claassen has received publishing royalties from a publication relating to health care.
Daniel R. Gold, DO	Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer . Dr. Gold has received publishing royalties from a publication relating to health care.
Simy K. Parikh, MD	Dr. Parikh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Parikh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. Dr. Parikh has received personal compensation in the range of $500-$4,999 for serving as a Author with Medlink. Dr. Parikh has received personal compensation in the range of $500-$4,999 for serving as a Faculty with Touch Independent Medical ��ɫ�� (touchIME) . Dr. Parikh has a non-compensated relationship as a Medical Advisory Board Member with Spinal CSF Leak Foundation that is relevant to AAN interests or activities.
Randolph S. Marshall, MD, FAAN	The institution of Dr. Marshall has received research support from NIH. Dr. Marshall has received publishing royalties from a publication relating to health care.
Saurav Das, MD	Dr. Das has nothing to disclose.
Rishi Sharma, MD	Dr. Sharma has nothing to disclose.
Guido J. Falcone, MD	The institution of Dr. Falcone has received research support from NIH. The institution of Dr. Falcone has received research support from AHA.
Sandra Martin	Sandra Martin has nothing to disclose.
Corbin Stephens, MD	Dr. Stephens has nothing to disclose.
Mark Hogan	No disclosure on file
Zachariah Hasan, MD	Dr. Hasan has nothing to disclose.
Stacey Clardy, MD, PhD, FAAN	Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory, Penn State, Mayo Clinic, Walter Reed.
Joseph I. Sirven, MD, FAAN	Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Sirven has received publishing royalties from a publication relating to health care. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as a Host/ Co producer with WJCT Public Media. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Federal Aviation Administration .
Roy E. Strowd III, MD, FAAN	Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks . Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.
Laura J. Balcer, MD, MSCE, FAAN	An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Chad W. Farris, MD, PhD	Mr. Farris has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Imaging Core Lab, Inc.. The institution of Mr. Farris has received research support from National Institute on Aging.
Mitchell S. Elkind, MD, MS, FAAN	Dr. Elkind has received personal compensation for serving as an employee of American Heart Association. Dr. Elkind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atria Academy.
Rachel Forman, MD	Dr. Forman has nothing to disclose.
Soojin Park, MD	Dr. Park has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical Care. The institution of Dr. Park has received research support from National Institutes of Health.
Valentina Quintana, Jr., MD	Dr. Quintana has nothing to disclose.
Sumita M. Strander	Ms. Strander has nothing to disclose.
Jean Christophe Corvol, MD	No disclosure on file
Steven R. Messe, MD, FAHA, FAAN	Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Terumo. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for WL Gore. The institution of Dr. Messe has received research support from WL Gore. The institution of Dr. Messe has received research support from Mallinkrodt. The institution of Dr. Messe has received research support from Biogen. Dr. Messe has received intellectual property interests from a discovery or technology relating to health care. Dr. Messe has received publishing royalties from a publication relating to health care. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving as a Clinical Event Committee for the CONFORMAL left atrial appendage occlusion trial with Yale Cardiovascular Research Group.
Sukhraj Gill, MD	Dr. Gill has nothing to disclose.
Saketh Annam, MBBS	Dr. Annam has nothing to disclose.
Heather Moss, MD, PhD, FAAN	Dr. Moss has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Verana Health. Dr. Moss has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Firms. The institution of Dr. Moss has received research support from NIH. The institution of Dr. Moss has received research support from Research to Prevent Blindness. Dr. Moss has received intellectual property interests from a discovery or technology relating to health care. Dr. Moss has received personal compensation in the range of $0-$499 for serving as a grant review panel with National Institutes of Health. Dr. Moss has a non-compensated relationship as a Board of Directors with North American Neuro-ophthalmology Society that is relevant to AAN interests or activities.
Stephen G. Reich, MD, FAAN	Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Best Doctors. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UpToDate. Dr. Reich has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. Dr. Reich has received publishing royalties from a publication relating to health care. Dr. Reich has received publishing royalties from a publication relating to health care.
Jose Gutierrez, MD	Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cardiovascular Research Foundation. Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for White and Rusell. Dr. Gutierrez has received research support from NIH. Dr. Gutierrez has received publishing royalties from a publication relating to health care. Dr. Gutierrez has received publishing royalties from a publication relating to health care.
Doris G. Leung, MD	The institution of Dr. Leung has received research support from US Department of Defense. The institution of Dr. Leung has received research support from Fulcrum Therapeutics. The institution of Dr. Leung has received research support from ML Bio Solutions, Inc.. The institution of Dr. Leung has received research support from Sarepta Therapeutics. The institution of Dr. Leung has received research support from Cumberland Pharmaceuticals. The institution of Dr. Leung has received research support from FibroGen Inc.. The institution of Dr. Leung has received research support from Astellas Pharma. The institution of Dr. Leung has received research support from University of Kansas Medical Center Research Institute. The institution of Dr. Leung has received research support from Pfizer, Inc.. The institution of Dr. Leung has received research support from Harmony Biosciences. The institution of Dr. Leung has received research support from Edgewise Therapeutics. The institution of Dr. Leung has received research support from F. Hoffmann-La Roche AG. The institution of Dr. Leung has received research support from Asklepios BioPharmaceutical, Inc.. The institution of Dr. Leung has received research support from Avidity Biosciences. The institution of Dr. Leung has received research support from Virginia Commonwealth University. The institution of Dr. Leung has received research support from Seattle Children's Hospital.
Nihal Satyadev, MD, MPH	Dr. Satyadev has nothing to disclose.
Michael G. Benatar, MBChB, DPhil, FAAN	Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for Annexon. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for UniQure. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cartesian. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CorEvitas. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Canopy. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alaunos. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Woolsey. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Benatar has received intellectual property interests from a discovery or technology relating to health care.
William S. Burgin, MD	Dr. Burgin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for VuEssence. Dr. Burgin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Burgin has stock in VuEssence. The institution of Dr. Burgin has received research support from VuEssence. The institution of Dr. Burgin has received research support from Bristol-Myers Squibb. The institution of Dr. Burgin has received research support from ReNeuron.
Jonathan R. Galli, MD	Dr. Galli has nothing to disclose.
Stephen Krieger, MD, FAAN	Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle. The institution of Dr. Krieger has received research support from Novartis. The institution of Dr. Krieger has received research support from Bristol Myers Squibb. The institution of Dr. Krieger has received research support from Biogen. The institution of Dr. Krieger has received research support from Sanofi.
Nuri Jacoby, MD, FAAN	Dr. Jacoby has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Jacoby has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for N/A.
Deborah I. Friedman, MD, MPH, FAAN	Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Friedman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Pfizer. Dr. Friedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsone. Dr. Friedman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Pfizer. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology . Dr. Friedman has a non-compensated relationship as a Program Co-Chair, Scottsdale Headache Symposium with American Headache Society that is relevant to AAN interests or activities. Dr. Friedman has a non-compensated relationship as a Medical Advisor with Spinal CSF Leak Foundation that is relevant to AAN interests or activities. Dr. Friedman has a non-compensated relationship as a President-elect, Board of Directors with Southern Headache Society that is relevant to AAN interests or activities.
Charlene Gamaldo, MD, FAAN	Dr. Gamaldo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for johns hopkins. Dr. Gamaldo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. Dr. Gamaldo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Gamaldo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Apnimed. The institution of Dr. Gamaldo has received research support from NIH/NIMH/NIDA/NINDS. Dr. Gamaldo has received publishing royalties from a publication relating to health care.
Avindra Nath, MD, MBBS, FAAN	The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from Target ALS. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care.
Michael R. Vincent, MBA, FACHE	Mr. Vincent has nothing to disclose.
Alexis Brice, MD	Dr. Brice has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for ICM.
Bela Ajtai, MD	Dr. Ajtai has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Ifrah Zawar, MD	The institution of Dr. Zawar has received research support from Alzheimer's association. The institution of Dr. Zawar has received research support from American epilepsy society . The institution of Dr. Zawar has received research support from NIH. The institution of Dr. Zawar has received research support from University of Virginia.
Steven Shirk	Steven Shirk has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with ICRG.
Nolan Campbell	Nolan Campbell has received personal compensation for serving as an employee of Biogen. Nolan Campbell has stock in Biogen.
David E. Hale, Jr., MD	Dr. Hale has nothing to disclose.
Robert A. Bermel, MD, FAAN	Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
Teng J. Peng, MD	Dr. Peng has nothing to disclose.
Kailash P. Bhatia, MD, FAAN	Dr. Bhatia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Bhatia has received publishing royalties from a publication relating to health care.
Victor Liaw, MD	Dr. Liaw has nothing to disclose.
Daniela B. Renedo, MD	Dr. Renedo has nothing to disclose.
Marcio N. Souza, MD	Dr. Souza has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Lilly. Dr. Souza has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Souza has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for TEVA. Dr. Souza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Libbs. Dr. Souza has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Abbvie.
Louise-Laure Mariani, MD, PhD	Dr. Mariani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Oculis. Dr. Mariani has received personal compensation in the range of $0-$499 for serving as a Consultant for Merz. Dr. Mariani has received personal compensation in the range of $0-$499 for serving as a Consultant for Emeis. Dr. Mariani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Paris Brain Institute. Dr. Mariani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Owkin. Dr. Mariani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Elivie. Dr. Mariani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Mariani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DIGITAL MEDICAL HUB. Dr. Mariani has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for John Libbey. The institution of Dr. Mariani has received research support from France Parkinson Association. The institution of Dr. Mariani has received research support from Fondation de France. The institution of Dr. Mariani has received research support from Paris Brain Institute. The institution of Dr. Mariani has received research support from French Ministry of Health. Dr. Mariani has received intellectual property interests from a discovery or technology relating to health care.
Timothy Lynch, MD	Dr. Lynch has nothing to disclose.
Dirk Smeets	Dirk Smeets has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for icometrix. Dirk Smeets has stock in icometrix.
Gregory F. Wu, MD, FAAN	Dr. Wu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Progentec. Dr. Wu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wu has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimmunology. Dr. Wu has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Department of Justice. The institution of Dr. Wu has received research support from EMD Serono. The institution of Dr. Wu has received research support from Biogen.
Deepaneeta Sarmah, M Pharm	Miss Sarmah has nothing to disclose.
Xue Yang, MD, PhD	Dr. Yang has nothing to disclose.
Kamleshun Ramphul	Kamleshun Ramphul has nothing to disclose.
Ronald J. Killiany, PhD	Dr. Killiany has nothing to disclose.
Kelly G. Knupp, MD	The institution of Dr. Knupp has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony. Dr. Knupp has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Research.
Bianca Palushaj, MD	Dr. Palushaj has nothing to disclose.
Phil Schmitt, MD	Dr. Schmitt has nothing to disclose.
Azima Shaji, MD, MBBS	Dr. Shaji has nothing to disclose.
Yulia Y. Orlova, MD, PhD	Dr. Orlova has nothing to disclose.
Ziv Gan-Or, MD, PhD	Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuron23. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Gan-Or has received personal compensation in the range of $0-$499 for serving as a Consultant for Lighthouse. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Handl Therapeutics. Dr. Gan-Or has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial Biotech.
Suzanne Lesage, PhD	Dr. Lesage has nothing to disclose.
David S. Liebeskind, MD, FAAN	Dr. Liebeskind has received research support from Cerenovus. Dr. Liebeskind has received research support from Genentech . Dr. Liebeskind has received research support from Medtronic. Dr. Liebeskind has received research support from Stryker.
Charmaine Demanuele, PhD	Dr. Demanuele has received personal compensation for serving as an employee of Pfizer. Dr. Demanuele has stock in Pfizer.
Sharon Hassin-Baer, MD	Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ABBVIE. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MEDISON. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBVIE. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA.
Quentin Howlett-Prieto	Mr. Howlett-Prieto has nothing to disclose.
Lori Chibnik	No disclosure on file
Anthony L. Ritaccio, MD, FAAN	The institution of Dr. Ritaccio has received research support from NIH. Dr. Ritaccio has received intellectual property interests from a discovery or technology relating to health care.
Thurman M. Wheeler, MD	Dr. Wheeler has nothing to disclose.
Marcia E. Morita-Sherman, MD	An immediate family member of Dr. Morita-Sherman has received personal compensation for serving as an employee of Forrester Research. Dr. Morita-Sherman has received personal compensation for serving as an employee of Eisai Inc.. An immediate family member of Dr. Morita-Sherman has stock in Forrester Research. The institution of Dr. Morita-Sherman has received research support from Cleveland Clinic.
Anand Kumar, MD, DM	Dr. Kumar has nothing to disclose.
Danielle S. Shpiner, MD	An immediate family member of Dr. Shpiner has received personal compensation for serving as an employee of University of Miami. Dr. Shpiner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Mission MSA. The institution of Dr. Shpiner has received research support from American Parkinson's Disease Association. The institution of Dr. Shpiner has received research support from CurePSP. The institution of Dr. Shpiner has received research support from Parkinson's Foundation. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Parkinson's Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Medtronic that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Boston Scientific that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbott that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbvie that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Ipsen that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Amneal that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Michael J. Fox Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a CoC Medical Director with CurePSP that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Mission MSA that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Merz that is relevant to AAN interests or activities.
David Irwin, MD	The institution of Dr. Irwin has received research support from NIH. The institution of Dr. Irwin has received research support from Prevail. The institution of Dr. Irwin has received research support from Passage Bio. The institution of Dr. Irwin has received research support from Alector. The institution of Dr. Irwin has received research support from Transposon. The institution of Dr. Irwin has received research support from Denali. The institution of Dr. Irwin has received research support from Cervo Med.
Yi-Cheng Zhu, MD, PhD	Dr. Zhu has nothing to disclose.
Bryan Paulo L. Canlas, DO	Dr. Canlas has nothing to disclose.
Maysaa M. Basha, MD, FAAN	Dr. Basha has nothing to disclose.
Bakri Elsheikh, MD, FAAN	Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen . Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argnex . The institution of Dr. Elsheikh has received research support from Biogen. The institution of Dr. Elsheikh has received research support from Cure SMA.
Oury Monchi, PhD	The institution of Dr. Monchi has received research support from Canadian Health Research Institutes. The institution of Dr. Monchi has received research support from National Science and Engineering and Research Council of Canada. The institution of Dr. Monchi has received research support from Brain Canada Parkinson Canada.
Sairah Bashir, MD, FAAN	Dr. Bashir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic .
Stefanie Mason, MD	Dr. Mason has received personal compensation for serving as an employee of Sarepta. Dr. Mason has stock in Sarepta. An immediate family member of Dr. Mason has stock in Sarepta. The institution of an immediate family member of Dr. Mason has received research support from Biogen. The institution of Dr. Mason has received research support from NIH. The institution of Dr. Mason has received research support from Chest Foundation.
Steven K. Feske, MD	Dr. Feske has received publishing royalties from a publication relating to health care.
William D. Arnold, MD	Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for La Hoffmann Roche. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadent Therapeutics . Dr. Arnold has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Arnold has received research support from NIH. The institution of Dr. Arnold has received research support from NMD Pharma. The institution of Dr. Arnold has received research support from Gilead Sciences. The institution of Dr. Arnold has received research support from CureSMA. Dr. Arnold has received intellectual property interests from a discovery or technology relating to health care.
Julia Klein, NP	An immediate family member of Ms. Klein has received personal compensation for serving as an employee of Amgen. An immediate family member of Ms. Klein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen.
Kelly Ditrapani	Kelly Ditrapani has received personal compensation for serving as an employee of Avidity Biosciences. Kelly Ditrapani has received personal compensation for serving as an employee of Iovance Biotherapeutics. An immediate family member of Kelly Ditrapani has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Kelly Ditrapani has stock in Iovance Biotherapeutics. Kelly Ditrapani has stock in Avidity Biosciences. Kelly Ditrapani has stock in Aravive Inc.. An immediate family member of Kelly Ditrapani has stock in Jazz Pharmaceuticals. Kelly Ditrapani has stock in Abbvie.
Stephen J. Kolb, MD, PhD	Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AveXis. Dr. Kolb has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CureSMA. The institution of Dr. Kolb has received research support from NIH. The institution of Dr. Kolb has received research support from AveXis. The institution of Dr. Kolb has received research support from NIH.
Nikita Urval, MD	Dr. Urval has nothing to disclose.
Lindsay N. Alfano, PT	Ms. Alfano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ATOM International, Ltd (Amicus Therapeutics, Catabasis, Genethon, Italfarmaco, NS Pharma, Pfizer, PTC Therapeutics). Ms. Alfano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta Therapeutics. The institution of Ms. Alfano has received research support from Novartis Gene Therapies. The institution of Ms. Alfano has received research support from Sarepta Therapeutics. The institution of Ms. Alfano has received research support from Audentes Therapeutics/Astellas Gene Therapies. Ms. Alfano has received intellectual property interests from a discovery or technology relating to health care.
Lukasz Milanowski, MD	Dr. Milanowski has nothing to disclose.
Mohankumar Kurukumbi, MD	Dr. Kurukumbi has nothing to disclose.
Thor D. Stein, MD, PhD	Dr. Stein has nothing to disclose.
Roua Kahila, MD	Dr. Kahila has nothing to disclose.
Adam S. Deardorff, MD	Dr. Deardorff has nothing to disclose.
Shufan Huo, MD, PhD	Dr. Huo has nothing to disclose.
Vanessa Merker	The institution of Vanessa Merker has received research support from Children's Tumor Foundation . The institution of Vanessa Merker has received research support from NF Northeast. The institution of Vanessa Merker has received research support from Patient Centered Outcomes Research Institute. The institution of Vanessa Merker has received research support from U.S. Department of Defense . The institution of Vanessa Merker has received research support from Neurofibromatosis Therapeutic Accleration Project. Vanessa Merker has received personal compensation in the range of $10,000-$49,999 for serving as a Science Writer with Neurofibromatosis Network.
Shanindra De Alwis, MD, MBBS	Dr. De Alwis has nothing to disclose.
Konstantin Senkevich, MD	The institution of Dr. Senkevich has received research support from MJFF. Dr. Senkevich has received research support from HBHL. Dr. Senkevich has received research support from FRQS.
Hsin-Pin Lin, MD, PhD	Dr. Lin has nothing to disclose.
Antonio Gil-Nagel, MD	Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EISAI . Dr. Gil-Nagel has received personal compensation in the range of $0-$499 for serving as a Consultant for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Angelini Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke . Dr. Gil-Nagel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zogenix . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EISAI . Dr. Gil-Nagel has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PTC Therapeutics . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zogenix . The institution of Dr. Gil-Nagel has received research support from Jazz Pharmaceuticals. The institution of Dr. Gil-Nagel has received research support from PTC Therapeutics. The institution of Dr. Gil-Nagel has received research support from Zogenix. The institution of Dr. Gil-Nagel has received research support from Agencia Estatal Innovacion.
Jose Murguia Fuentes	No disclosure on file
Carolyn Conlon	Ms. Conlon has nothing to disclose.
Nishant K. Mishra, MD, MBBS, PhD, FESO	Dr. Mishra has nothing to disclose.
Kush Sharma, MBBS	Dr. Sharma has nothing to disclose.
Erum Khan	Ms. Khan has nothing to disclose.
Michelle L. Mellion, MD	Dr. Mellion has received personal compensation for serving as an employee of PepGen. Dr. Mellion has stock in PepGen.
Sherry Fung	Ms. Fung has nothing to disclose.
Anne E. Hiniker, MD	Dr. Hiniker has nothing to disclose.
Amanda Glickman	Ms. Glickman has nothing to disclose.
Tarun Girotra, MD	Dr. Girotra has nothing to disclose.
Ferhat Erol, MD	Dr. Erol has nothing to disclose.
Ezekiel Gonzalez-Fernandez, MD	Dr. Gonzalez-Fernandez has nothing to disclose.
Dylan T. Ryan, MD	Dr. Ryan has nothing to disclose.
Terry D. Heiman-Patterson, MD	Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Heiman-Patterson has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Heiman-Patterson has received research support from MTPA. The institution of Dr. Heiman-Patterson has received research support from State of Pennsylvania . The institution of Dr. Heiman-Patterson has received research support from ALS Association. The institution of Dr. Heiman-Patterson has received research support from ALS United. The institution of Dr. Heiman-Patterson has received research support from ALS Hope Foundation.
Mamatha Pasnoor, MD, FAAN	Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen.
Ihtsham Haq, MD, FAAN	The institution of Dr. Haq has received research support from NINDS. The institution of Dr. Haq has received research support from the Parkinson's Foundation.
Marisa P. McGinley, DO	Dr. McGinley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. McGinley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. McGinley has received research support from Biogen. The institution of Dr. McGinley has received research support from Genentech. The institution of Dr. McGinley has received research support from NIH. The institution of Dr. McGinley has received research support from AHRQ. The institution of Dr. McGinley has received research support from EMD Serono.
Traci Aladeen, PharmD	Dr. Aladeen has nothing to disclose.
Clemens R. Scherzer, MD	Dr. Scherzer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Scherzer has received research support from NIH. The institution of Dr. Scherzer has received research support from Michael J. Fox Foundation. The institution of Dr. Scherzer has received research support from American Parkinson's Disease Association. Dr. Scherzer has received intellectual property interests from a discovery or technology relating to health care.
Krithika Umesh Peshwe, MD	Dr. Peshwe has nothing to disclose.
Gary W. Clauser, MD	Dr. Clauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bigoen . The institution of Dr. Clauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Clauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech . Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genzyme. Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Novartid.
Yoonkyung Chang, MD	Dr. Chang has nothing to disclose.
Seward B. Rutkove, MD, FAAN	Dr. Rutkove has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Myolex, Inc. Dr. Rutkove has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neuorlogy . The institution of Dr. Rutkove has received research support from NIH. The institution of Dr. Rutkove has received research support from NASA. The institution of Dr. Rutkove has received research support from Blavatnik Family Foundation. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Mohammad M. Samara, MD	Dr. Samara has nothing to disclose.
Jacqueline E. Summers Stromberg, MD	An immediate family member of Dr. Summers Stromberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Life Science Angels. An immediate family member of Dr. Summers Stromberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Userwise Consulting.
Abby L. Olsen, MD	An immediate family member of Dr. Olsen has received personal compensation for serving as an employee of Rheos Medicines. An immediate family member of Dr. Olsen has received personal compensation for serving as an employee of Novasenta. An immediate family member of Dr. Olsen has received personal compensation for serving as an employee of Biohaven. The institution of Dr. Olsen has received research support from NINDS. The institution of Dr. Olsen has received research support from DoD. The institution of Dr. Olsen has received research support from American Parkinson's Disease Association. The institution of Dr. Olsen has received research support from Alzheimer's Association.
Nada El Husseini, MD, FAAN	Dr. El Husseini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. El Husseini has received research support from the DISCOVERY trial funded by the National Institute of Neurological Disorders and Stroke (NINDS)and the National Institute on Aging (NIA) (U19NS115388).- subcontract from MGH. The institution of Dr. El Husseini has received research support from American Heart Association. The institution of Dr. El Husseini has received research support from PCORI.
John W. Rose, MD, FAAN	The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
S. Ahmad Sajjadi, MD, PhD, MRCP, FAAN	Dr. Sajjadi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GUIDEPOINT. Dr. Sajjadi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Research and Therapy. The institution of Dr. Sajjadi has received research support from NIH.
Wim Vandenberghe	Dr. Vandenberghe has nothing to disclose.
Suha Suliman	Miss Suliman has nothing to disclose.
Michel Abdelmasih, MD	Dr. Abdelmasih has nothing to disclose.
Neil W. Kowall, MD	Dr. Kowall has received publishing royalties from a publication relating to health care.
Shashwat Pokharel, MBBS	Dr. Pokharel has nothing to disclose.
Elizabeth Harrison, MD	Dr. Harrison has nothing to disclose.
Carmen Priego	Ms. Priego has nothing to disclose.
Michael S. Oldham, MD, MPH	Dr. Oldham has received personal compensation for serving as an employee of Praxis Precision Medicines.
Poornima Jayadev Menon, MbBchBAO, MRCPI	The institution of Dr. Jayadev Menon has received research support from Michael J Fox Foundation.
Jeffrey Statland, MD	Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vita Therapeutics. Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex . The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA.
Victor Wang, MD	Dr. Wang has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.
Dong Jin Shin, MD	Dr. Shin has nothing to disclose.
Piet C. De Groen, MD	Prof. De Groen has nothing to disclose.
Darshini Shah, Other	Ms. Shah has received personal compensation for serving as an employee of AbbVie. Ms. Shah has stock in AbbVie Inc. An immediate family member of Ms. Shah has received research support from National Institutes of Health.
Angela She, PhD	Dr. She has received personal compensation for serving as an employee of Viridian Therapeutics. Dr. She has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus Therapeutics. Dr. She has stock in Viridian Therapeutics.
Julette F. Batara, MD	Dr. Batara has nothing to disclose.
Doug Gunzler	No disclosure on file
Wade J. Whitt	Mr. Whitt has nothing to disclose.
Tsneem Mbydeen, MBBS	Dr. Mbydeen has nothing to disclose.
Aleksandra Antoniak	Miss Antoniak has nothing to disclose.
Danielle A. Griffin	Ms. Griffin has stock in Sarepta Therapeutics. Ms. Griffin has received intellectual property interests from a discovery or technology relating to health care.
Jason H. Margolesky, MD, FAAN	Dr. Margolesky has nothing to disclose.
Cole P. Denkensohn, MD	Dr. Denkensohn has nothing to disclose.
Nunzio Camerlingo, PhD	Dr. Camerlingo has received personal compensation for serving as an employee of Pfizer.
Sepideh Yadollahi, MD	Dr. Yadollahi has nothing to disclose.
RayLee Otero-Bell	Miss Otero-Bell has nothing to disclose.
Yorghos Tripodis	Yorghos Tripodis has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association.
Sofía S. Sánchez Boluarte, MD	The institution of Dr. Sánchez Boluarte has received research support from NIH.
Vera Zingler	Vera Zingler has received personal compensation for serving as an employee of Roche. Vera Zingler has stock in Roche.
Eric Lipp	No disclosure on file
Octavio Carranza-Renteria, MD	Dr. Carranza-Renteria has nothing to disclose.
Michael Alosco, PhD	The institution of Michael Alosco, PhD has received research support from NIH. The institution of Michael Alosco, PhD has received research support from Life Molecular Imaging Inc.
Claire Henchcliffe, MD, PhD, FAAN	Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tolmar. Dr. Henchcliffe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Savanna. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Meira GTx. Dr. Henchcliffe has or had stock in Axent Biosciences Inc. The institution of Dr. Henchcliffe has received research support from Weston Brain Institute. The institution of Dr. Henchcliffe has received research support from Blue Rock Therapeutics. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Parkinson Study Group. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Course director with AAN. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Cleveland Clinic Foundation. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Vertex. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with ESGCT.
Larry "LC" Charleston IV, MD, MSc, FAHS, FANA, FAAN	Dr. Charleston has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Charleston has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LinPharma. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Haleon. Dr. Charleston has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. The institution of Dr. Charleston has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsome. Dr. Charleston has or had stock in Mi-Helper Inc..Dr. Charleston has a non-compensated relationship as a Associate Editor with Headache Journal: The Journal of Head and Face Pain that is relevant to AAN interests or activities. Dr. Charleston has a non-compensated relationship as a Board Member with Clinical Neurological Society of America that is relevant to AAN interests or activities. Dr. Charleston has a non-compensated relationship as a Chair, EDI Advisory Committee (Non-voting Board Member) with American Headache Society that is relevant to AAN interests or activities.
Adam De Havenon, MD, FAAN	Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
Jaime Imitola, MD, FAAN	The institution of Dr. Imitola has received research support from Genentech. Dr. Imitola has a non-compensated relationship as a Board Member with National MS Society that is relevant to AAN interests or activities. Dr. Imitola has a non-compensated relationship as a Committee Member with International Society for Stem Cell Research that is relevant to AAN interests or activities.
Stanley Fahn, MD, FAAN	Dr. Fahn has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Stoparkinson Healthcare Systems, LLC; . Dr. Fahn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin Inc . Dr. Fahn has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Publishers . Dr. Fahn has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Kirkland & Ellis. Dr. Fahn has received publishing royalties from a publication relating to health care.
Katherine B. Peters, MD, PhD, FAAN	Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sapience. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ONO Pharmaceutical. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telix. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AnHeart. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rigel. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nuvation. The institution of Dr. Peters has received research support from Biomimetix. The institution of Dr. Peters has received research support from Servier. The institution of Dr. Peters has received research support from Varian. The institution of Dr. Peters has received research support from Sapience. The institution of Dr. Peters has received research support from Ono Pharmaceuticals/Deciphera. The institution of Dr. Peters has received research support from Nuvation. The institution of Dr. Peters has received research support from Novocure. The institution of Dr. Peters has received research support from Curis.
Cyprien Rivier, MD	Dr. Rivier has nothing to disclose.
Richard S. Nicholas, FRCP	Dr. Nicholas has nothing to disclose.
Johan Van Beek, PhD	Dr. Van Beek has nothing to disclose.
Deborah Forst, MD	Dr. Forst has stock in Eli Lilly. Dr. Forst has received research support from Conquer Cancer Foundation of the American Society of Clinical Oncology. Dr. Forst has received research support from Palliative Care Research Cooperative Group. Dr. Forst has received research support from American Cancer Society Institutional Research Grant.
Zarife F. Sahenk, MD, PhD, FAAN	Dr. Sahenk has nothing to disclose.
David J. Roh, MD	Dr. Roh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Portola Pharmaceuticals.
Sean Siguenza, MD	Mr. Siguenza has nothing to disclose.
Sarah Cawley	Miss Cawley has nothing to disclose.
Alexei Goraltchouk, Other	Mr. Goraltchouk has received personal compensation for serving as an employee of Remedium Bio, Inc. Mr. Goraltchouk has stock in Remedium Bio, Inc..
Nameer Aladamat, MBBS	Dr. Aladamat has nothing to disclose.
Evanthia Bernitsas, MD, FAAN	Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vanda. The institution of Dr. Bernitsas has received research support from Roche/Genentech.
Juan P. Cabrera Pulla, MD	Dr. Cabrera Pulla has nothing to disclose.
Andrew M. Blumenfeld, MD, FAAN	Dr. Blumenfeld has received personal compensation for serving as an employee of The Los Angeles Headache Center. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctors. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GLG. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revance. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Axsome. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cedar Sinai. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AXSOME.
Elizabeth M. Monohan, MD	Dr. Monohan has nothing to disclose.
Robert Fekete, MD	Dr. Fekete has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine Biosciences, Inc.. Dr. Fekete has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acorda, Inc.. Dr. Fekete has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Fekete has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva Neuroscience, Inc.. Dr. Fekete has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia Pharmaceutical, Inc.. Dr. Fekete has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin, Inc.. Dr. Fekete has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Adamas Pharmaceutical, Inc.. Dr. Fekete has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine Biosciences, Inc.. Dr. Fekete has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal Pharmaceuticals, Inc.. Dr. Fekete has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda Therapeutics, Inc.. Dr. Fekete has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion, Inc.. Dr. Fekete has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink, Inc.. The institution of Dr. Fekete has received research support from Lundbeck. Dr. Fekete has received publishing royalties from a publication relating to health care. Dr. Fekete has a non-compensated relationship as a Neurological Working Group Member with Alliance for Patient Access that is relevant to AAN interests or activities.
Aanini Dwivedi	Ms. Dwivedi has nothing to disclose.
Megan Iammarino, PT	Dr. Iammarino has nothing to disclose.
Michael A. De Georgia, MD	Dr. De Georgia has nothing to disclose.
Drew L. Cheng	Mr. Cheng has nothing to disclose.
M. M. Paz Soldan, MD, PhD	Dr. Paz Soldan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Paz Soldan has received research support from National Institutes of Health. The institution of Dr. Paz Soldan has received research support from National Multiple Sclerosis Society. The institution of Dr. Paz Soldan has received research support from Western Institute for Biomedical Research. The institution of Dr. Paz Soldan has received research support from Biogen. The institution of Dr. Paz Soldan has received research support from Novartis. The institution of Dr. Paz Soldan has received research support from Clene Nanomedicine.
Christine Holmstedt, DO	The institution of Dr. Holmstedt has received research support from NIH. The institution of Dr. Holmstedt has received research support from Patient-Centered Outcomes Research Institute.
Krzysztof M. Bochenek, MD	Dr. Bochenek has stock in JNJ, Abbott, Moderna, Pfizer.
Sama Noroozi Gilandehi, MD	Dr. Noroozi Gilandehi has nothing to disclose.
Nestor Beltre, MD	Dr. Beltre has nothing to disclose.
Henry P. Moore, MD	Dr. Moore has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Moore has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen Pharma. The institution of Dr. Moore has received research support from Sage Therapeutics. The institution of Dr. Moore has received research support from Bukwang Pharmaceutical. The institution of Dr. Moore has received research support from Neurocrine. The institution of Dr. Moore has received research support from CDHI Foundation. The institution of Dr. Moore has received research support from MODUS Outcomes LLC. The institution of Dr. Moore has received research support from University of Kansas Center for Research.
Maia Schlechter	Ms. Schlechter has nothing to disclose.
Christopher Adams, MD	Dr. Adams has stock in Medtronic.
Deepti Zutshi, MD, FAAN	Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon pharmaceuticals. An immediate family member of Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aucta.
Aracelis Torres	No disclosure on file
Sumin Kim, MD	Dr. Kim has nothing to disclose.
Luca Chiveri, MD	Dr. Chiveri has nothing to disclose.
Michael L. Edgeworth, MD, MSc, FAAN	Dr. Edgeworth has received personal compensation for serving as an employee of Octave Bioscience. Dr. Edgeworth has received personal compensation for serving as an employee of Nira Medical. Dr. Edgeworth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Altoida. Dr. Edgeworth has stock in Cigna. Dr. Edgeworth has stock in OnCall Health Corporation, DBA Cayaba Care.
Courtney Venegas, MD	Dr. Venegas has nothing to disclose.
Carlos Singer, MD	Dr. Singer has nothing to disclose.
Alexa C. Caffio-Learner	Ms. Caffio-Learner has nothing to disclose.
Kasim Qureshi, MD	Dr. Qureshi has nothing to disclose.
Wim Van Hecke, PhD	Dr. Van Hecke has received personal compensation for serving as an employee of icometrix.
Yesenia Enriquez-Gonzalez, MD	Dr. Enriquez-Gonzalez has nothing to disclose.
Francesco Sacca, MD, FAAN	Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lexeo. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genpharm. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medpharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Madison Pharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zai Lab. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reata. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neopharm Israel. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson&Johnson. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Sacca has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Astrazeneca. The institution of Dr. Sacca has received research support from AIFA. The institution of Dr. Sacca has received research support from FARA.
Nicolas Dupre, MD, FAAN	Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation.
Russell J. Van Coevering III, MD	Dr. Van Coevering has nothing to disclose.
Mark L. Moster, MD, FAAN	Dr. Moster has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Gensight . Dr. Moster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viridian. Dr. Moster has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Kilcoyne and Nesbitt.
Muhammad Farooq, MD	Dr. Farooq has nothing to disclose.
Vincenzo Brescia Morra, MD	Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALMIRALL. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERK. Dr. Brescia Morra has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MERK. The institution of Dr. Brescia Morra has received research support from FISM. Dr. Brescia Morra has a non-compensated relationship as a PI with FISM that is relevant to AAN interests or activities.
Adrian Rodriguez-Hernandez, MD	Dr. Rodriguez-Hernandez has nothing to disclose.
Yaacov Anziska, MD	Dr. Anziska has nothing to disclose.
Niranjan N. Singh, MD, FAAN	Dr. Singh has nothing to disclose.
Morgan McCreary	Morgan McCreary has nothing to disclose.
Roberto P. Ortega, MD	No disclosure on file
Atuyota L. Orogun, MBBS	Dr. Orogun has nothing to disclose.
Dania Qaryouti, MD	Dr. Qaryouti has nothing to disclose.
Natalie Reash	No disclosure on file
Lauren M. Webb, MD	Dr. Webb has nothing to disclose.
Sydney Mosaheb, MS	Miss Mosaheb has nothing to disclose.
Manuela Altieri	No disclosure on file
Cheryl Bushnell, MD, MHS	The institution of Dr. Bushnell has received research support from PCORI. The institution of Dr. Bushnell has received research support from NIH/NINDS. Dr. Bushnell has received intellectual property interests from a discovery or technology relating to health care. Dr. Bushnell has received publishing royalties from a publication relating to health care.
Jesse B. Mez, MD	The institution of Dr. Mez has received research support from NIH, DOD.
Atanu Biswas, MD	Dr. Biswas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for INTAS Pharmaceuticals. Dr. Biswas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for lupin Limited. Dr. Biswas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alkem Laboratories. Dr. Biswas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Torrent Pharmaceuticals.
Antonio Gallo	Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis.
Kevin N. Sheth, MD, FAAN	Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Trieste Francis	Miss Francis has nothing to disclose.
Dheeraj D. Lalwani	Mr. Lalwani has nothing to disclose.
Varun K. Singh, MD, MBBS	Dr. Singh has nothing to disclose.
Claire S. Peterson	Ms. Peterson has nothing to disclose.
Larry Hansen	No disclosure on file
Ashhar Ali, DO, FAAN	Dr. Ali has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Ali has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Ebsco.
Srikar Tallavajhala	Mr. Tallavajhala has nothing to disclose.
Jan O. Aasly, MD, PhD	No disclosure on file
Michael T. Mullen, MD	Dr. Mullen has received publishing royalties from a publication relating to health care.
Kathryn Sands	No disclosure on file
Rod Middleton	The institution of Mr. Middleton has received research support from MS Society.
Asad Ikram, MD, MBBS	Dr. Ikram has nothing to disclose.
Letizia M. Leocani, MD	Dr. Leocani has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche . Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Med-ex learning.
Traci Kazmerski	The institution of Traci Kazmerski has received research support from Cystic Fibrosis Foundation. The institution of Traci Kazmerski has received research support from NIH.
Ming Shen, Other	Ms. Shen has nothing to disclose.
Rameshwar N. Chaurasia, MD, DM, FRCP (Edin), FAMS	Dr. Chaurasia has nothing to disclose.
Alvino Bisecco	Alvino Bisecco has nothing to disclose.
Vineetha Yadlapalli	Miss Yadlapalli has nothing to disclose.
Yiran Sun	No disclosure on file
Mark S. Quigg, MD	Dr. Quigg has received personal compensation for serving as an employee of Natus. Dr. Quigg has received personal compensation for serving as an employee of Neurocrine. Dr. Quigg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerebral Therapeutics. Dr. Quigg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerebral Therapeutics. Dr. Quigg has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Finnigen and Harrison. Dr. Quigg has received research support from NIH. Dr. Quigg has received publishing royalties from a publication relating to health care.
Sung-Wook Yu	The institution of Sung-Wook Yu has received research support from Yuhan.
Mya C. Schiess, MD, FAAN	Dr. Schiess has nothing to disclose.
Allison M. Ho, MD	Ms. Ho has nothing to disclose.
J. Helen Cross	Dr. Cross has nothing to disclose.
Tatiana Greige, MD	Dr. Greige has nothing to disclose.
Shreyas Gangadhara, MD, FAAN	Dr. Gangadhara has nothing to disclose.
Anudeeta Gautam	Miss Gautam has nothing to disclose.
Orrin Devinsky, MD, FAAN	Dr. Devinsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for California Cannabis Enterprises. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Privateer Holdings. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Receptor Holdings. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rettco. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Silver Spike. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tevard. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Tilray. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Tevard Biosciences. Dr. Devinsky has stock in Engage. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in California Cannabis Enterprises. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in Silver Spike. Dr. Devinsky has stock in Docklight Brands. Dr. Devinsky has stock in Egg Rock/Papa Barkley. Dr. Devinsky has stock in Leafly. Dr. Devinsky has stock in Left Coast Ventures. Dr. Devinsky has stock in Privateer Holdings. Dr. Devinsky has stock in Receptor Holdings. Dr. Devinsky has stock in Qstate. The institution of Dr. Devinsky has received research support from GW Pharma. The institution of Dr. Devinsky has received research support from Zogenix. The institution of Dr. Devinsky has received research support from PTC Pharma. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from DOD. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from Epilepsy Foundation. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NSF. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received publishing royalties from a publication relating to health care.
Kunal Bonde, MBBS	Dr. Bonde has nothing to disclose.
Hamid Ali, MBBS	Dr. Ali has nothing to disclose.
Marla Hairston	No disclosure on file
Nicholas R. Delcimmuto, MD	Mr. Delcimmuto has nothing to disclose.
Deborah M. Miller, PhD	Dr. Miller has received intellectual property interests from a discovery or technology relating to health care.
Ghazaleh Ahmadi Jazi, MD	Dr. Ahmadi Jazi has nothing to disclose.
Fahham Asghar, MD	Mr. Asghar has nothing to disclose.
Sachin Agarwal, MD, MPH	Dr. Agarwal has nothing to disclose.
Roy Alcalay, MD	Dr. Alcalay has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme/Sanofi. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gain Therapeutics. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vanqua Bio. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Capsida. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. The institution of Dr. Alcalay has received research support from Michael J. Fox Foundation. The institution of Dr. Alcalay has received research support from Parkinson's Foundation. The institution of Dr. Alcalay has received research support from Silverstein Foundation. Dr. Alcalay has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with Parkinson's Foundation.
Melissa Funaro	Melissa Funaro has nothing to disclose.
Duaa Jabari, MD	Dr. Jabari has nothing to disclose.
Tyler Kuhns, MD	Mr. Kuhns has nothing to disclose.
Michael Schwarzschild, MD, PhD	The institution of Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial Biotech (indirectly, as a service of the Parkinson Study Group service). The institution of Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen (indirectly, as a service of the Parkinson Study Group service). The institution of Dr. Schwarzschild has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB (indirectly, as a service of the Parkinson Study Group service). Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. The institution of Dr. Schwarzschild has received research support from NIH. The institution of Dr. Schwarzschild has received research support from Parkinson's Foundation. The institution of Dr. Schwarzschild has received research support from Michael J Fox Foundation. The institution of Dr. Schwarzschild has received research support from Farmer Family Foundation. Dr. Schwarzschild has a non-compensated relationship as a Chair, Executive Committee with the Parkinson Study Group that is relevant to AAN interests or activities.
Christopher Streib, MD	Dr. Streib has nothing to disclose.
Nils Lucca Kern	Mr. Kern has nothing to disclose.
Joanne Wuu, SCM	The institution of Ms. Wuu has received research support from NIH NINDS. The institution of Ms. Wuu has received research support from NIH NCATS/NINDS. The institution of Ms. Wuu has received research support from CDC. The institution of Ms. Wuu has received research support from Target ALS. The institution of Ms. Wuu has received research support from ALS Recovery Fund. The institution of Ms. Wuu has received research support from NIH/NINDS. The institution of Ms. Wuu has received research support from NIH NINDS. The institution of an immediate family member of Ms. Wuu has received research support from NIH NINDS.
Lauryn Hemminger	Dr. Hemminger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Michel A. Ritenuti, DO	Dr. Ritenuti has nothing to disclose.
Andrea S. Yoo, MD	Dr. Yoo has nothing to disclose.
Emily Tharp, MD	Dr. Tharp has nothing to disclose.
Benjamin J. Dorfman, MD	Dr. Dorfman has nothing to disclose.
Jeffrey Lahrmann, MD	Dr. Lahrmann has nothing to disclose.
Monica Lemmon, MD	Dr. Lemmon has received research support from NINDS. Dr. Lemmon has received research support from BAND foundation. Dr. Lemmon has received research support from Doris Duke Charitable Foundation. Dr. Lemmon has received research support from Child Neurology Society.
Uddalak Chakraborty, MD, MBBS	Dr. Chakraborty has nothing to disclose.
Alejandro R. Marfil-Rivera, MD	Dr. Marfil-Rivera has nothing to disclose.
Joanne Fielding	No disclosure on file
Jagan Pillai, MD, PhD, FAAN	Dr. Pillai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Nature. Dr. Pillai has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Treatment Options in Neurology. The institution of Dr. Pillai has received research support from Alzheimer's Association. The institution of Dr. Pillai has received research support from Keep Memory Alive Foundation . The institution of Dr. Pillai has received research support from NIA. Dr. Pillai has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with DOD. Dr. Pillai has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with RGC Hong kong.
Erafat Rehim, MD	Dr. Rehim has nothing to disclose.
Daniela Lozano, MD	Dr. Lozano has nothing to disclose.
Rachel Kenney	Rachel Kenney has received personal compensation for serving as an employee of Optum. Rachel Kenney has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Minton ��ɫ�� LLC.
Eric A. Macklin, PhD	The institution of Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AI Therapeutics. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chase Therapeutics. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial Biotech. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson Healthcare LLC. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Macklin has received research support from Biohaven. The institution of Dr. Macklin has received research support from Clene Nanomedicine. The institution of Dr. Macklin has received research support from Mitsubishi Tanabe Pharmaceuticals America. The institution of Dr. Macklin has received research support from Prilenia. The institution of Dr. Macklin has received research support from UCB Ra Pharma. The institution of Dr. Macklin has received research support from Revalesio. The institution of Dr. Macklin has received research support from Seelos. The institution of Dr. Macklin has received research support from Calico. The institution of Dr. Macklin has received research support from Denali. The institution of Dr. Macklin has received research support from NeuroDex. The institution of Dr. Macklin has received research support from Alector. The institution of Dr. Macklin has received research support from ITB-Med.
Mandy Hatfield, MD	Dr. Hatfield has nothing to disclose.
Ilene Hollin	The institution of Ilene Hollin has received research support from MT Pharma. The institution of Ilene Hollin has received research support from PCORI. The institution of Ilene Hollin has received research support from PCORI. The institution of Ilene Hollin has received research support from Shriners Hospital for Children. The institution of Ilene Hollin has received research support from NIH/NIDDK. The institution of Ilene Hollin has received research support from NIH/NHLBI. Ilene Hollin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with New Horizons, a division of Global Health Labs.
Catherine R. Craven, MD	Dr. Craven has nothing to disclose.
Mark C. Stahl, MD, PhD	Dr. Stahl has received personal compensation for serving as an employee of Avidity Biosciences. Dr. Stahl has stock in Avidity Biosciences.
Christopher Walsh, MD, PhD	Dr. Walsh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Maze therapeutics. Dr. Walsh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Third Rock Ventures. Dr. Walsh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Flagship Pioneering. Dr. Walsh has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology.
Tae-Jin Song, MD	Dr. Song has nothing to disclose.
Megumi Sugita, DO	Dr. Sugita has nothing to disclose.
Melody T. Asukile, MBBS	Dr. Asukile has received research support from Royal Society for Tropical Medicine and Hygiene. The institution of Dr. Asukile has received research support from Leverhulme Trust. Dr. Asukile has received personal compensation in the range of $0-$499 for serving as a meeting speaker with American Neurological Association.
Ann N. Ly, MD	Dr. Ly has nothing to disclose.
María F. Castillo Vaca	Ms. Castillo Vaca has nothing to disclose.
Kee Duk Park, MD	No disclosure on file
Derek Narendra, MD	The institution of Dr. Narendra has received research support from National Institutes of Health.
Maryam Zulfiqar, MD	Dr. Zulfiqar has nothing to disclose.
Tammy L. Smith, MD, PhD	Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Smith has received research support from Alexion/AstraZeneca.
Philippe Ryvlin, MD, PhD	Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arvelle/Angelini. The institution of Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB pharma. The institution of Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini pharma. The institution of Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB pharma. The institution of Dr. Ryvlin has received research support from Swiss National Fund. The institution of Dr. Ryvlin has received research support from European Commission (Horizon Europe).
Utku Uysal, MD	Dr. Uysal has nothing to disclose.
Sulada Kanchana, MD, PhD	Dr. Kanchana has nothing to disclose.
Pegah Afra, MD, FAAN	The institution of Dr. Afra has received research support from Neuroelectrics. The institution of Dr. Afra has received research support from Xenon Pharmaceuticals. Dr. Afra has a non-compensated relationship as a board member (representing AAN) with CoA-NDT that is relevant to AAN interests or activities.
Ann C. McKee, MD	Dr. McKee has nothing to disclose.
Celine Maes	No disclosure on file
Kelly Lehman, MSN, CNP	Ms. Lehman has nothing to disclose.
Xuemei Cai, MD, FAAN	Dr. Cai has received personal compensation for serving as an employee of Pfizer. Dr. Cai has stock in Pfizer.
Duarte G. Machado, MD, FAAN	Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Huw R. Morris, MD, PhD	Dr. Morris has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aprinoia. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Morris has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Personal injury / Negligence cases. The institution of Dr. Morris has received research support from Parkinson's UK. The institution of Dr. Morris has received research support from Michael J Fox Foundartion. The institution of Dr. Morris has received research support from Cure Parkinson's Trust. The institution of Dr. Morris has received research support from PSP Association. The institution of Dr. Morris has received research support from CBD Solutions. The institution of Dr. Morris has received research support from Drake Foundation. The institution of Dr. Morris has received research support from Medical Research Council. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has a non-compensated relationship as a Scientific Advisory Board with Cure PSP that is relevant to AAN interests or activities. Dr. Morris has a non-compensated relationship as a Scientific Advisory Board with Parkinson's UK that is relevant to AAN interests or activities.
Taylor Haddad, MD	Ms. Haddad has nothing to disclose.
Eliza C. Miller, MD	Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medical malpractice cases. The institution of Dr. Miller has received research support from National Institutes of Health. Dr. Miller has a non-compensated relationship as a member of ASA Advisory Council with American Heart Association/American Stroke Association that is relevant to AAN interests or activities.
Reza Abbasi-Asl, PhD	Prof. Abbasi-Asl has received research support from NIH. Prof. Abbasi-Asl has received research support from Weill Neurohub.
Khaled Gharaibeh, MD	Dr. Gharaibeh has nothing to disclose.
Vivekananda Ramana	No disclosure on file
Elizabeth Celente, DO	Dr. Celente has nothing to disclose.
Michael Strupp, MD, DO, FAAN	Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertify. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IntraBio. Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vifor, Frisenius, CH. Dr. Strupp has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers. Dr. Strupp has stock in IntraBio.
Kelley Del Real	Kelley Dalby has received personal compensation for serving as an employee of Praxis Precision Medicines. Kelley Dalby has stock in Praxis Precision Medicines. Kelley Dalby has stock in RogCon.
Sarah Germaine, DO	Dr. Germaine has nothing to disclose.
Shashvat Desai, MD	Dr. Desai has nothing to disclose.
Ajaz Sheikh, MD	Dr. Sheikh has nothing to disclose.
Alberto Ascherio, MD, PhD	Dr. Ascherio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Ascherio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ascherio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Ascherio has received research support from NIH and US Department of Defense .
Deepika Joshi, MD	Dr. Joshi has nothing to disclose.
Pallab Bhattacharya, PhD	Dr. Bhattacharya has nothing to disclose.
Terry Quinn	No disclosure on file
Alexis Trujillo, MD	Miss Trujillo has nothing to disclose.
Jay L. Alberts, PhD	Dr. Alberts has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceraxis. Dr. Alberts has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceraxis. The institution of Dr. Alberts has received research support from NIH. The institution of Dr. Alberts has received research support from Department of Defense. The institution of Dr. Alberts has received research support from Michael J. Fox Foundation. Dr. Alberts has received intellectual property interests from a discovery or technology relating to health care. Dr. Alberts has received personal compensation in the range of $500-$4,999 for serving as a Member, Health and Wellness Council with Peloton Interactive.
Naaima Mufti, MD	Dr. Mufti has nothing to disclose.
Nicholas Levitt	Nicholas Levitt has received personal compensation for serving as an employee of Biogen Inc..
Bhaswar Bhattacharya, Jr.	Dr. Bhattacharya has nothing to disclose.
Giacomo Lus	Giacomo Lus has nothing to disclose.
Elisabetta Signoriello	Elisabetta Signoriello has nothing to disclose.
Aya A. Ouf, MBBS	Dr. Ouf has nothing to disclose.
Ricardo Murguia Fuentes, MD	Dr. Murguia Fuentes has nothing to disclose.
Alrabi Tawil, MD, FAAN	Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving as a Consultant for meRicule. The institution of Dr. Tawil has received research support from Friends of FSH Research. The institution of Dr. Tawil has received research support from FSH Society. The institution of Dr. Tawil has received research support from NIH. The institution of Dr. Tawil has received research support from Fulcrum. Dr. Tawil has received intellectual property interests from a discovery or technology relating to health care.
Richard Shell	No disclosure on file
Eddie Darton	No disclosure on file
Jeff Rodgers	Jeff Rodgers has nothing to disclose.
Valerie A. Block, DPTSc	Dr. Block has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Block has received research support from National MS Society.
David G. Coughlin, MD	Dr. Coughlin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. The institution of Dr. Coughlin has received research support from ��ɫ��. The institution of Dr. Coughlin has received research support from NIA. The institution of Dr. Coughlin has received research support from NINDS.
Annemie Ribbens	Annemie Ribbens has received personal compensation for serving as an employee of icometrix. Annemie Ribbens has stock in icometrix. Annemie Ribbens has received intellectual property interests from a discovery or technology relating to health care.
Mudassir Farooqui, MD	Dr. Farooqui has nothing to disclose.
Jaideep Kapur, MD, PhD	The institution of Dr. Kapur has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus. Dr. Kapur has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Robert Wood Johnson Foundation . Dr. Kapur has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Kapur has received research support from NIH. Dr. Kapur has received intellectual property interests from a discovery or technology relating to health care. Dr. Kapur has a non-compensated relationship as a Chair, Board North America with International League against Epilepsy that is relevant to AAN interests or activities. Dr. Kapur has a non-compensated relationship as a Board of Directors with American Epilepsy Society that is relevant to AAN interests or activities.
Shivani Ghoshal, MD	Dr. Ghoshal has nothing to disclose.
Peter J. Schwab, MD	Dr. Schwab has nothing to disclose.
Lauren R. Moo, MD, FAAN	Dr. Moo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pilltrax. An immediate family member of Dr. Moo has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. Dr. Moo has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Smith Mirabella Blake. The institution of Dr. Moo has received research support from VA HSR&D. The institution of Dr. Moo has received research support from VA Office of Rural Health. Dr. Moo has received research support from NIH.
Yoshimi Sogawa, MD	Dr. Sogawa has nothing to disclose.
Alisha Qaiser, MD	Dr. Qaiser has nothing to disclose.
Noora C. Haghighi, MS	Miss Haghighi has nothing to disclose.
Andrea Bozeman, NP	Mrs. Bozeman has nothing to disclose.
L D. DeWitt, MD	Dr. DeWitt has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Sarah Marmol, MD	Dr. Marmol has nothing to disclose.
Syed A. Quadri, MD	Dr. Quadri has nothing to disclose.
Ugur Sener, MD	Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier Pharmaceuticals. Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Hyunji Kim	Ms. Kim has nothing to disclose.
Michelle Rainka, PharmD	Dr. Rainka has stock in Abbvie. Dr. Rainka has stock in acadia. Dr. Rainka has stock in alon. Dr. Rainka has stock in biogen. Dr. Rainka has stock in bristol myers squib. Dr. Rainka has stock in eisai. Dr. Rainka has stock in Lilly. Dr. Rainka has stock in novartis. Dr. Rainka has stock in pfizer. Dr. Rainka has stock in roche. Dr. Rainka has stock in Sage. Dr. Rainka has stock in alkermes.
Karol Sadowski	Mr. Sadowski has nothing to disclose.
Mary Claire Tuohy	Ms. Tuohy has nothing to disclose.
Katerina Mensikova	Katerina Mensikova has nothing to disclose.
Svetlana Faktorovich, MD, FAAN	Dr. Faktorovich has a non-compensated relationship as a member of the Board of Trustees with Brother's Brother Foundation that is relevant to AAN interests or activities.
Haitham Hussein, MD, FAAN	Dr. Hussein has nothing to disclose.
Daniel Ontaneda, MD, PhD, FAAN	Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Ontaneda has received research support from NIH. The institution of Dr. Ontaneda has received research support from PCORI. The institution of Dr. Ontaneda has received research support from NMSS. The institution of Dr. Ontaneda has received research support from Genetech.
Ece Eldem, MSc	Ms. Eldem has nothing to disclose.
Robert Stern, PhD	Robert Stern, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Robert Stern, PhD has received research support from Eisai. The institution of Robert Stern, PhD has received research support from Lilly. The institution of Robert Stern, PhD has received research support from ATRI/NIA. Robert Stern, PhD has received publishing royalties from a publication relating to health care. Robert Stern, PhD has a non-compensated relationship as a Member with NFLPA Mackey-White Committee that is relevant to AAN interests or activities.
Amit Kandel, MD	Dr. Kandel has nothing to disclose.
Audrey Leasure	Ms. Leasure has nothing to disclose.
Rasha Moussallem, MD	Dr. Moussallem has nothing to disclose.
Laura A. Kirkpatrick, MD	The institution of Dr. Kirkpatrick has received research support from American Epilepsy Society. The institution of Dr. Kirkpatrick has received research support from Child Neurologist Career Development Program. The institution of Dr. Kirkpatrick has received research support from Child Neurology Foundation. The institution of Dr. Kirkpatrick has received research support from Rosenau Family Research Foundation. The institution of Dr. Kirkpatrick has received research support from Society of Family Planning. The institution of Dr. Kirkpatrick has received research support from Pediatric Epilepsy Research Consortium. Dr. Kirkpatrick has received personal compensation in the range of $500-$4,999 for serving as a Meeting Attendee with One8 Foundation. Dr. Kirkpatrick has received personal compensation in the range of $500-$4,999 for serving as a Meeting Attendee with Brigham and Women's Hospital. Dr. Kirkpatrick has received personal compensation in the range of $0-$499 for serving as a Meeting Attendee with Pediatric Epilepsy Research Consortium. Dr. Kirkpatrick has received personal compensation in the range of $0-$499 for serving as a Grant reviewer with Society of Family Planning. Dr. Kirkpatrick has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Norton Children's Hospital. Dr. Kirkpatrick has a non-compensated relationship as a Board of Directors member with My Epilepsy Story that is relevant to AAN interests or activities.
Ka-Ho Wong	The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association.
Oriana Sanchez, MD	Dr. Sanchez has nothing to disclose.
Laur Marius Birlea, MD, FAAN	Dr. Birlea has nothing to disclose.
Jenifer Moceri, DO	Dr. Moceri has nothing to disclose.
Diogo Garcia	No disclosure on file
Dickson Munkombwe, MD	Dr. Munkombwe has nothing to disclose.
William O. Tatum IV, DO, FAAN	Dr. Tatum has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bioserenity. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Defense Law Firm on behalf of a patient with epilepsy with funds donated to the Epilepsy Foundation of America. The institution of Dr. Tatum has received research support from Esai. The institution of Dr. Tatum has received research support from Mayo Clinic. The institution of Dr. Tatum has received research support from Liva Nova. The institution of Dr. Tatum has received research support from Engage Pharmaceuticals. The institution of Dr. Tatum has received research support from Xenon. Dr. Tatum has received intellectual property interests from a discovery or technology relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has a non-compensated relationship as a AAN Section Chair of Clinical Neurophysiology with AAN that is relevant to AAN interests or activities.
Padmaja Sudhakar, MD	Dr. Sudhakar has nothing to disclose.
John Crary	John Crary has nothing to disclose.
Yuan Cao	Ms. Cao has nothing to disclose.
Lakshman N. Arcot Jayagopal, MD	Dr. Arcot Jayagopal has nothing to disclose.
Teresa Brandt	Teresa Brandt has received personal compensation for serving as an employee of Avidity Biosciences. Teresa Brandt has received personal compensation for serving as an employee of Acadia Pharmaceuticals. Teresa Brandt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia Pharmaceuticals. Teresa Brandt has stock in Avidity Biosciences.
Gina Norato	Gina Norato has nothing to disclose.
Ian L. Dimaandal, MD	Dr. Dimaandal has nothing to disclose.
Paulo Gonzalez, DO	Dr. Gonzalez has nothing to disclose.
Sihyeong Park, MD	Dr. Park has nothing to disclose.
Amelia K. Adcock, MD	The institution of an immediate family member of Dr. Adcock has received research support from NIH.
Robert Kadish, MD	Dr. Kadish has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Kadish has received research support from Alexion Pharmaceuticals.
Lauren H. Sansing, MD	Dr. Sansing has nothing to disclose.
Yongya Kim	No disclosure on file
Pranusha Pinna, DO	Dr. Pinna has nothing to disclose.
William C. Nichols, PhD	No disclosure on file
Tahsin Khan, MD	Dr. Khan has nothing to disclose.
Joy A. DeMarcaida, MD	The institution of Dr. DeMarcaida has received research support from Pharma2B. The institution of Dr. DeMarcaida has received research support from Neuroderm. The institution of Dr. DeMarcaida has received research support from Sage Therapeutics.
Sojung Park, DO	Dr. Park has nothing to disclose.
Michael Carrithers, MD, PhD	The institution of Dr. Carrithers has received research support from Biogen.
Chezhian D	No disclosure on file
Nethra Parasuram	No disclosure on file
Chokri A. Mhiri, MD	Prof. Mhiri has received personal compensation for serving as an employee of Hikma. Prof. Mhiri has received personal compensation for serving as an employee of Sanofi Genzyme. Prof. Mhiri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Prof. Mhiri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Farid Khasiyev, MD	Dr. Khasiyev has nothing to disclose.
Robert Beach, MD, PhD, FAAN	The institution of Dr. Beach has received research support from Neurona.
Elizabeth A. Fracica, MD, MPH	Dr. Fracica has nothing to disclose.
Henry Houlden	No disclosure on file
Maryam Matloub, MD	Dr. Matloub has nothing to disclose.
Melissa A. Wright, MD	Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis .
Elena Bortan, MD	Dr. Bortan has nothing to disclose.
Tjalf Ziemssen, MD, FAAN	Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
Christopher C. Anderson, MD	Dr. Anderson has received publishing royalties from a publication relating to health care.
Christine Klein, MD	Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Centogene and Retromer Therapeutics. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Mov Disord, Ann Neurol, Science Adv. The institution of Dr. Klein has received research support from Centogene. Dr. Klein has received publishing royalties from a publication relating to health care.
Ati Ghoreyshi	No disclosure on file
Debbie Cohen	Debbie Cohen has nothing to disclose.
Grace Crotty, MD	The institution of Dr. Crotty has received research support from Parkinson's Foundation. The institution of Dr. Crotty has received research support from ��ɫ��.
Gil D. Rabinovici, MD, FAAN	Dr. Rabinovici has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Rabinovici has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Norodisk. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for C2N. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Joihnson. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Peerview. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA. The institution of Dr. Rabinovici has received research support from NIH. The institution of Dr. Rabinovici has received research support from American College of Radiology. The institution of Dr. Rabinovici has received research support from Alzheimer's Association. The institution of Dr. Rabinovici has received research support from Rainwater Charitable Foundation. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Topic Chair, Course Director and teacher with AAN. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with ANA.
Jade S. Schiffman, MD	The institution of Dr. Schiffman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Schiffman has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for lAW FIRMS. Dr. Schiffman has received intellectual property interests from a discovery or technology relating to health care.
Emmanuel Roze, MD, PhD	Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for merz. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving as a Consultant for orkyn. Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for elivie. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for allergan. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Orkyn. Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for elivie. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aguettant. The institution of Dr. Roze has received research support from merz. The institution of Dr. Roze has received research support from Orkyn. Dr. Roze has received research support from elivie. The institution of Dr. Roze has received research support from allergan. The institution of Dr. Roze has received research support from fondation desmarest. The institution of Dr. Roze has received research support from everpharma. Dr. Roze has received research support from AMADYS. The institution of Dr. Roze has received research support from ADCY5.org. The institution of Dr. Roze has received research support from agence nationale de la recherche. The institution of Dr. Roze has received research support from société française de médecine esthétique. The institution of Dr. Roze has received research support from dystonia medical research foundation.
Virginia Gao, MD	Dr. Gao has nothing to disclose.
Swetha Renati, MD	Dr. Renati has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Renati has received personal compensation in the range of $500-$4,999 for serving as a NeuroSAE with ��ɫ�� .
John K. Lynch, DO, MPH	Dr. Lynch has nothing to disclose.
Kristina M. Kelly, PT	Dr. Kelly has nothing to disclose.
Sarah Heintzman, NP	Ms. Heintzman has nothing to disclose.
Dimitri Krainc, MD, PhD	Dr. Krainc has nothing to disclose.
James B. Leverenz, MD, FAAN	Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leverenz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai.
Xiaoyu Jiang	Xiaoyu Jiang has received personal compensation for serving as an employee of Sanofi.
Rana K. Zabad, MD, FAAN	Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene/BMS. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Neurosciences. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. The institution of Dr. Zabad has received research support from Adamas. The institution of Dr. Zabad has received research support from Biogen. The institution of Dr. Zabad has received research support from Novartis. The institution of Dr. Zabad has received research support from Sun Pharma. The institution of Dr. Zabad has received research support from Parexel & MedDay Pharmaceuticals.
Rachel J. Saunders-Pullman, MD	The institution of Dr. Saunders-Pullman has received research support from NIH, Bigglesworth Family Foundation, Empire Clinical Research Investigatory Program.
Renuka Verma	Renuka Verma has nothing to disclose.
Stella L. Ngo, PhD	Dr. Ngo has received personal compensation for serving as an employee of Neurelis Inc.. Dr. Ngo has received personal compensation for serving as an employee of Neurelis Inc..
Anooshah E. Ata, MD	Dr. Ata has nothing to disclose.
Dena Garner, PhD	Dr. Garner has received stock or an ownership interest from blinktbi, inc.
Mohammad A. Shahab, MD, MBBS	Dr. Shahab has nothing to disclose.
Cleo Zarina A. Reyes, MD	Dr. Reyes has nothing to disclose.
Nicole Girlyn T. Pang, MD	Dr. Pang has nothing to disclose.
Mariel Pullman, MD	The institution of Dr. Pullman has received research support from Empire Clinical Research Investigator Program.
Andrea C. Wasilewski, MD	Dr. Wasilewski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure. Dr. Wasilewski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier Pharmaceuticals .
Sonia Kaur Singh, MD	Dr. Singh has nothing to disclose.
Jerina Carmona, Other	Miss Carmona has nothing to disclose.
Omar Jawdat, MD	Dr. Jawdat has nothing to disclose.
Kendra M. Anderson, PhD	Dr. Anderson has nothing to disclose.
Yongwoo Kim, MD	Dr. Kim has nothing to disclose.
Corneliu C. Luca, MD	Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health. Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott.
Scott R. Plotkin, MD, PhD, FAAN	Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NFlection Therapeutics. Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Akouos. Dr. Plotkin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SonALAsense. Dr. Plotkin has stock in NFlection Therapeutics. Dr. Plotkin has stock in NF2 Therapeutics. Dr. Plotkin has stock in SonALAsense. Dr. Plotkin has received research support from Children's Tumor Foundation. Dr. Plotkin has received research support from Department of Defense. Dr. Plotkin has received research support from National Institutes of Health. Dr. Plotkin has received intellectual property interests from a discovery or technology relating to health care.
Vaibhav Goswami, MD	Dr. Goswami has nothing to disclose.
Shivam Patel, MD	Mr. Patel has nothing to disclose.
Angela M. Velazquez, MD	Dr. Velazquez has nothing to disclose.
Scheherazade Le, MD	Dr. Le has nothing to disclose.
Ryan Pinosky	Mr. Pinosky has nothing to disclose.
Arayamparambil Anilkumar, MD, FAAN	Dr. Anilkumar has received publishing royalties from a publication relating to health care.
Thy Nguyen, MD	Dr. Nguyen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for ArgenX. Dr. Nguyen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Nguyen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Nguyen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Nguyen has received publishing royalties from a publication relating to health care.
Juan F. Gongora Rivera, MD, MD, MSc, PhD	Dr. Gongora Rivera has nothing to disclose.
Alfredo Quinones-Hinojosa	Alfredo Quinones-Hinojosa has nothing to disclose.
Abhishek Pathak, MD, MBBS, DM	Dr. Pathak has nothing to disclose.
Cassie L. Nankee, MD	Dr. Nankee has nothing to disclose.
Heidi Kirsch, MD	The institution of Dr. Kirsch has received research support from Ricoh, Inc.
Uladzislau Rudakou	Mr. Rudakou has nothing to disclose.
Atif Zafar, MD	Dr. Zafar has nothing to disclose.
Shufang Wang	No disclosure on file
Eric N. Beck, MB, BCH, BAO	Dr. Beck has nothing to disclose.
Maria L. Moro-de-Casillas, MD	An immediate family member of Dr. Moro-de-Casillas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. An immediate family member of Dr. Moro-de-Casillas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intuitive. The institution of Dr. Moro-de-Casillas has received research support from Davis Phinney Foundation.
Robert A. Rissman, PhD	Dr. Rissman has nothing to disclose.
Sailaja Sanikommu, MBBS	Dr. Sanikommu has nothing to disclose.
Jacqueline M. Behr, NP	Mrs. Behr has nothing to disclose.
Giancarlo Comi, MD	Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Shikha Polega	Shikha Polega has received personal compensation for serving as an employee of UCB. Shikha Polega has stock in UCB. Shikha Polega has stock in Zogenix.
Breton Asken	Breton Asken has nothing to disclose.
Anna Schwartz	No disclosure on file
Azizi Seixas	No disclosure on file
Bang-Hoon Cho	Bang-Hoon Cho has nothing to disclose.
Farren Briggs, PhD	The institution of Prof. Briggs has received research support from NIH.
Neel Fotedar, MD	Dr. Fotedar has received research support from NINDS.
Linda P. Lowes, PT PhD	The institution of Ms. Lowes has received research support from Sarepta Therapeutics.
Kaleb H. Yohay, MD	Dr. Yohay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Yohay has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Yohay has received publishing royalties from a publication relating to health care.
Kelly L. Block, DO	Dr. Block has nothing to disclose.
Sana Syed, MD	Dr. Syed has received personal compensation for serving as an employee of Sanofi US.
Haroutiun Hamzoian, MD	Dr. Hamzoian has nothing to disclose.
Shivani Pahwa, MD	Dr. Pahwa has nothing to disclose.
Petra Dirks	Petra Dirks has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd .
Collette Kokikian, MD	Dr. Kokikian has nothing to disclose.
Petr Kanovsky, PhD	Dr. Kanovsky has nothing to disclose.
Nidhi Checka	Miss Checka has nothing to disclose.
Leon Meytin, MD	Dr. Meytin has nothing to disclose.
Jane Larkindale, PhD	Dr. Larkindale has received personal compensation for serving as an employee of PepGen.
Lieven G. Lagae, PhD	Dr. Lagae has nothing to disclose.
Iris Chin, PhD	Dr. Chin has received personal compensation for serving as an employee of Verana Health.
Justin Y. Garber, MBBS	Dr. Garber has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Garber has received research support from Trish MS Foundation.
Deborah Raymond	The institution of Ms. Raymond has received research support from NIH.
Simona Bonavita	No disclosure on file
Ezequiel A. Piccione, MD, FAAN	Dr. Piccione has nothing to disclose.
Christianne Mojica	Christianne Mojica has nothing to disclose.
Lauren Grobois, MD	Dr. Grobois has nothing to disclose.
Carmen Serrano, MD, FAAN	The institution of Dr. Serrano has received research support from Eli Lilly. The institution of Dr. Serrano has received research support from Abbvie.
Susmit Tripathi, MD	Dr. Tripathi has nothing to disclose.
Jennifer N. Serventi, PA	Ms. Serventi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure.
Rebecca L. Hurst, MD	Dr. Hurst has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for The Paul Wilkinson law firm.
Krystian Solis, MD	Dr. Solis has nothing to disclose.
Diane D. Shao, MD, PhD	Dr. Shao has nothing to disclose.
Carley A. Ellis, MD	Dr. Carter has nothing to disclose.
Sarah Shapiro	Miss Shapiro has nothing to disclose.
Marina Buciuc, MD	Dr. Buciuc has nothing to disclose.
Matthew Feldman, MD	Dr. Feldman has nothing to disclose.
Elizabeth Thiele, MD	Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GW Pharma/Jazz. Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for zogenix/UCB. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for nobelpharma. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for livanova. Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Noema Pharma. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for pyros pharmaceutical/upsher smith. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. The institution of Dr. Thiele has received research support from GW Pharma/Jazz. The institution of Dr. Thiele has received research support from Zogenix/UCB. The institution of Dr. Thiele has received research support from Stoke Therapeutics. The institution of Dr. Thiele has received research support from Biocodex. Dr. Thiele has received publishing royalties from a publication relating to health care.
Rachael Potter	No disclosure on file
Edwin P. Conquest III	Mr. Conquest has nothing to disclose.
Julia Zabinska	Ms. Zabinska has nothing to disclose.
Gloria I. Ortiz Guerrero, MD	Dr. Ortiz Guerrero has nothing to disclose.
Matthew Gooden	Matthew Gooden has nothing to disclose.
Ivan John Clement	Mr. Clement has received personal compensation for serving as an employee of Novartis. Mr. Clement has stock in Roche.
Erin Dennis, MD	Dr. Dennis has nothing to disclose.
Gloria Dalla Costa	No disclosure on file
Mahmoud Elkhooly, MD	Dr. Elkhooly has nothing to disclose.
Jessika Suescun, MD	Dr. Suescun has nothing to disclose.
Steven L. Lewis, MD, FAAN	Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for American Board of Psychiatry and Neurology. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Lewis has received publishing royalties from a publication relating to health care. Dr. Lewis has a non-compensated relationship as a Secretary General with World Federation of Neurology that is relevant to AAN interests or activities.
Kathleen Church	No disclosure on file
Gregory Heinonen	Mr. Heinonen has nothing to disclose.
Jerry R. Mendell, MD, FAAN	Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta.
Brian J. Hanrahan, MD	Dr. Hanrahan has received personal compensation for serving as an employee of Nowyouknow Neuro.
Sandeep Gill, MD	Dr. Gill has nothing to disclose.
Lauren Reoma, MD, FAAN	Dr. Reoma has received research support from NIH. Dr. Reoma has a non-compensated relationship as a Vice Chair with AAN Experimental Neurotherapeutics Section that is relevant to AAN interests or activities. Dr. Reoma has a non-compensated relationship as a Federal Employee with NINDS/NIH that is relevant to AAN interests or activities. Dr. Reoma has a non-compensated relationship as a Member with ASENT Program Committee that is relevant to AAN interests or activities.
Sanaz Arezoumandan, MD	Sanaz Arezoumandan, MD has nothing to disclose.
Sarah Huntwork-Rodriguez, PhD	Dr. Huntwork-Rodriguez has received personal compensation for serving as an employee of Denali Therapeutics. Dr. Huntwork-Rodriguez has stock in Denali Therapeutics. Dr. Huntwork-Rodriguez has received intellectual property interests from a discovery or technology relating to health care.
Charlene L. Gunasekera, MD	Dr. Gunasekera has nothing to disclose.
Brin Freund, MD	Dr. Freund has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Freund has received research support from Mayo Clinic.
Andrea P. Lee, MD	Dr. Lee has nothing to disclose.
Susan B. Bressman, MD, FAAN	The institution of Dr. Bressman has received research support from Michael J Fox Foundation . The institution of Dr. Bressman has received research support from NIH .
Chandra Sekhar Mannyam, MBBS	Dr. Mannyam has nothing to disclose.
Marcos Arreola Flores, MD	Dr. Arreola Flores has nothing to disclose.
Prajwal Hegde, MD	Mr. Hegde has nothing to disclose.
Alessandro d'Ambrosio	Alessandro d'Ambrosio has nothing to disclose.
Sara W. Hyman	Ms. Hyman has nothing to disclose.
Rachit Patil, MD	Dr. Patil has nothing to disclose.
Daniel B. Hier, MD, MBA, FAAN	Dr. Hier has nothing to disclose.
Seyhmus Aydemir, MD	Dr. Aydemir has nothing to disclose.
Cheryl H. Waters, MD, FAAN	Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for US world meds. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexza. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acadia. Dr. Waters has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bial. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for US world meds. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal.
Rawan Albadareen, MD	Dr. Albadareen has nothing to disclose.
Mary Higginson, MD	Dr. Coughlin has nothing to disclose.
Azka Shaikh, MD	Dr. Shaikh has nothing to disclose.
J. David Avila, MD, FAAN	Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Avila has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda.
Mohammad N. Haider	Mr. Haider has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Blink TBI. Mr. Haider has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Blink CNS. Mr. Haider has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Oculogica Inc. Mr. Haider has stock in Headquarters Health. The institution of Mr. Haider has received research support from NIH. Mr. Haider has received research support from Headquarters Health. The institution of Mr. Haider has received research support from CDMRP/PRMRP.
Louise R. Rodino-Klapac	Ms. Rodino-Klapac has received personal compensation for serving as an employee of Sarepta Therapeutics, Inc.. Ms. Rodino-Klapac has received stock or an ownership interest from Sarepta Therapeutics. Ms. Rodino-Klapac has received intellectual property interests from a discovery or technology relating to health care.
Samarah Ahmed	Ms. Ahmed has nothing to disclose.
Pedro G. Paiva Bueno, MD	Dr. Bueno has nothing to disclose.
Leonard B. Hickman, MD	Dr. Hickman has nothing to disclose.
Rebecca Mayeda, MD	Ms. Mayeda has nothing to disclose.
Kapil Gururangan, MD	Dr. Gururangan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell Inc. Dr. Gururangan has stock in Ceribell Inc. The institution of Dr. Gururangan has received research support from NIH-NINDS. The institution of Dr. Gururangan has received research support from Leon Levy Foundation.
Adriana C. Mendez, MD	Dr. Mendez has nothing to disclose.
Anna Mattle, PharmD	Dr. Mattle has nothing to disclose.
Vijaya Mishra, MD, MBBS, DM	Prof. Mishra has nothing to disclose.
Timothy M. Ellmore, PhD	Prof. Ellmore has nothing to disclose.
Yasar T. Esengul, MD	Dr. Esengul has nothing to disclose.
Joshia John, MD	Ms. John has nothing to disclose.
Michelle M. Dagostine, MD	Dr. Dagostine has received personal compensation for serving as an employee of Adamas. Dr. Dagostine has received personal compensation for serving as an employee of Neurocrine. Dr. Dagostine has received personal compensation for serving as an employee of Boston Scientific. Dr. Dagostine has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Adamas. Dr. Dagostine has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Dagostine has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Adamas. Dr. Dagostine has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine.
Ashling Holland, PhD	Dr. Holland has received personal compensation for serving as an employee of PepGen Inc.. Dr. Holland has received intellectual property interests from a discovery or technology relating to health care.
Dawn C. Buse, PhD	Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranicsa. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
Amrou Sarraj, MD	Dr. Sarraj has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Sarraj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker Neurovascular. Dr. Sarraj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Stryker Neurovascular. The institution of Dr. Sarraj has received research support from Stryker Neurovascular.
Elizabeth J. Ackermann, PhD	Dr. Ackermann has received personal compensation for serving as an employee of Avidity Biosciences.
Lama Al-Khoury, MD	Dr. Al-Khoury has nothing to disclose.
Nitin Ramanujam Chakravarthula, MBBS	Dr. Chakravarthula has nothing to disclose.
Badria Munir, MD	Dr. Munir has nothing to disclose.
Shaheen Sombans, MBBS	Dr. Sombans has nothing to disclose.
Samantha Schaevitz	Samantha Schaevitz has nothing to disclose.
Maxx Yung	Maxx Yung has nothing to disclose.
Pulkith Paruchuri	Pulkith Paruchuri has nothing to disclose.
Mekdes Ditamo, DO	Dr. Ditamo has nothing to disclose.
Arjuna H. Fernando, MD, MBBS, MRCP	Dr. Fernando has nothing to disclose.
Marcio Souza	Marcio Souza has received personal compensation for serving as an employee of Praxis Precision Medicines.
Naim I. Haddad, MD, FAAN	Dr. Haddad has nothing to disclose.
Yanal R. Shaheen, MD	Dr. Shaheen has nothing to disclose.
Mohammed E. Abunaib, MD, MBBS	Dr. Abunaib has nothing to disclose.
Gayane R. Melikyan, MD, FAAN	Dr. Melikyan has nothing to disclose.
Areej Nauman, MD	Dr. Nauman has nothing to disclose.
Dirk T. Deleu, MD, PhD, FRCP, FAAN	Dr. Deleu has nothing to disclose.
Boulenouar Mesraoua, MD, FAAN	Dr. Mesraoua has nothing to disclose.
Hassan Jassim Al Hail, MD, FAAN	Dr. Al Hail has nothing to disclose.
Farah Wahbeh, MD	Ms. Wahbeh has nothing to disclose.
Jennifer Shoskes, PharmD	No disclosure on file
Thania F. Estrada Ortega	Miss Estrada Ortega has nothing to disclose.
Roberto A. Ortega, MS	Mr. Ortega has nothing to disclose.
Phoebe Jiang, PhD	Dr. Jiang has received personal compensation for serving as an employee of Biogen. Dr. Jiang has stock in Biogen.
Marie-Helene Jouvin	Marie-Helene Jouvin has received personal compensation for serving as an employee of Fulcrum Therapeutics. Marie-Helene Jouvin has received personal compensation for serving as an employee of Pharvaris. Marie-Helene Jouvin has stock in Fulcrum Therapeutics. Marie-Helene Jouvin has stock in Pharvaris.
Carla J. Schad, MD	Dr. Schad has received personal compensation for serving as an employee of UCB. Dr. Schad has received personal compensation for serving as an employee of Zogenix (now a part of UCB). Dr. Schad has stock in Zogenix/UCB.
Felix Guerra Castanon, MD	Dr. Guerra Castanon has nothing to disclose.
Andrew M. Southerland, MD, FAAN	Dr. Southerland has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Plaintiffs and Defense Cases related to Stroke and Vascular Neurology.. The institution of Dr. Southerland has received research support from American Heart Association. The institution of Dr. Southerland has received research support from NIH. The institution of Dr. Southerland has received research support from Abbvie Pharmaceuticals, Inc.. Dr. Southerland has received intellectual property interests from a discovery or technology relating to health care. Dr. Southerland has received intellectual property interests from a discovery or technology relating to health care.
Han Cho, PharmD	No disclosure on file
Kaitlin Dickinson, PhD	No disclosure on file
Kuntal Biswas, MD	Dr. Biswas has nothing to disclose.
Mallory Alonso, PharmD	Dr. Alonso has received personal compensation for serving as an employee of UCB, Inc.. Dr. Alonso has stock in UCB, Inc..
Brian Pfister	Dr. Pfister has received personal compensation for serving as an employee of Praxis Precisions Medicines. Dr. Pfister has stock in Praxis Precision Medicines.

��ɫ����

��ɫ����

��ɫ��

��ɫ��